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Für Emmi Noemi

Affidavit
Eidesstattliche Versicherung
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Summary
Various challenges arise during the treatment of lung tumors with stereotactic body ra-
diation therapy (SBRT), which is a form of hypofractionated high precision conformal
radiation therapy delivered to small targets. The dose is applied in only a few fractions
and respiratory organ and tumor motion is a source of uncertainty additional to inter-
fractional set-up errors. Respiratory organ and tumor motion is highly patient-specific
and it affects the whole radiotherapy treatment chain. In this thesis, motion management
techniques for SBRT are evaluated and improved in a clinical setting. A clinical need for
improvement has been present at the LMU university hospital for each issue addressed in
this thesis: Initially, the usage of respiratory correlated computed tomography (4DCT),
which is vital for SBRT treatment, was seen as impractical and prone to uncertainties in
the data reconstruction in its current form. Therefore, the 4DCT reconstruction workflow
has been improved to minimize these potential error sources. Secondly, treatment planning
for tumors affected by respiratory motion was evaluated and subsequently improved. Fi-
nally, the treatment technique of respiratory gating was implemented at the clinic, which
led to the need of evaluating the respiratory gating characteristics of the novel system
configuration.
At first, the 4DCT reconstruction workflow used in clinical practice was investigated,
as in the presence of respiratory motion the knowledge of tumor position over time is es-
sential in SBRT treatments. Using 4DCT, the full motion range of the individual tumor
can be determined. However, certain 4DCT reconstruction methods can under- or over-
estimate tumor motion due to limitations in the data acquisition scheme and due to the
incorrect sorting of certain X-ray computed tomography (CT) image slices into different
respiratory phases. As the regular clinical workflow of cycle-based sorting (CBS) without
maximum inspiration detection (and therefore no clear starting point for the individual
breathing cycles) seemed to be affected by these potential errors, the usage of CBS with
correct maximum detection and another sorting algorithm of the respiration states, so-
called local amplitude-based sorting (LAS), both have been implemented for a reduction
of image artifacts and improved 4DCT quality. The three phase binning algorithms have
been investigated in a phantom study (using 10 different breathing waveforms) and in a
patient study (with 10 different patients). The mis-representation of the tumor volume was
reduced in both implemented sorting algorithms compared to the previously used CBS ap-
proach (without correct maximum detection) in the phantom and the patient study. The
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clinical recommendation was the use of CBS with improved maximum detection, as too
many manual interventions would be needed for the LAS workflow.
Secondly, a combination of the actual patient breathing trace during treatment, the log
files generated by the linear accelerator (LINAC), and Monte Carlo (MC) four-dimensional
(4D) dose calculations for each individual fraction was implemented as a 4D dose evalua-
tion tool. This workflow was tested in a clinical environment for SBRT treatment planning
on multiple CT datasets featuring: a native free-breathing 3DCT, an average intensity
projection (AIP) as well as a maximum intensity projection (MIP), both obtained from
the patient’s 4DCT, and density overrides (DOs) in a 3DCT. This study has been carried
out for 5 SBRT patients for three-dimensional conformal radiation therapy (3D-CRT) and
volumetric modulated arc therapy (VMAT) treatment plans. The dose has been recal-
culated on each 4DCT breathing phase according the the patient’s breathing waveform
and accumulated to the gross tumor volume (GTV) at the end-of-exhale (EOE) breathing
phase using deformable image registration. Even though the least differences in planned
and recalculated dose were found for AIP and MIP treatment planning, the results indicate
a strong dependency on individual tumor motion due to the variability of breathing mo-
tion in general, and on tumor size. The combination of the patient’s individual breathing
trace during each SBRT fraction with 4D MC dose calculation based on the LINAC log
file information leads to a good approximation of actual dose delivery.
Finally, in order to ensure precise and accurate treatment for respiratory gating tech-
niques, the technical characteristics of the LINAC in combination with a breathing motion
monitoring system as s surrogate for tumor motion have to be identified. The dose delivery
accuracy and the latency of a surface imaging system in connection with a modern medical
LINAC were investigated using a dynamic breathing motion phantom. The dosimetric
evaluation has been carried out using a static 2D-diode array. The measurement of the
dose difference between gated and ungated radiation delivery was found to be below 1%
(for clinical relevant gating levels of about 30%). The beam-on latency, or time delay,
determined using radiographic films was found to be up to 851ms± 100ms. With these
known parameters, an adjustment of the pre-selected gating level or the internal target
volume (ITV) margins could be made.
With the highly patient-specific character of respiratory motion, lung SBRT faces many
additional challenges besides the specific issues addressed in this thesis. However, the find-
ings of this thesis have improved clinical workflows at the Department of Radiation Oncol-
ogy of the LMU University hospital. In a future perspective, a workflow using evaluation
of the actual 4D dose in combination with accurate 4DCT image acquisition and special-
ized treatment delivery (such as respiratory gating) has the potential for a safe further
reduction of treatment margins and increased sparing of organs-at-risk (OARs) in SBRT
without compromising tumor dose targeting accuracy.
Zusammenfassung
Die stereotaktische Radiotherapie (Englisch: stereotactic body radiation therapy
(SBRT)) zur Behandlung von Tumoren in der Lunge ist eine hypofraktionierte Hoch-
präzisionsbestrahlungstechnik für kleine Läsionen. Die Herausforderungen dabei be-
schränken sich nicht nur auf die Applikation einer hohen Dosis in nur wenigen Fraktionen
(was wenig Spielraum für Unsicherheiten zulässt), sondern beinhalten zusätzlich zu den
normalen interfraktionellen Lagerungsunsicherheiten auch die Atembeweglichkeit der Or-
gane und dementsprechend auch die Beweglichkeit der zu behandelnden Läsion. Die stark
patienten-spezifische Atembeweglichkeit beeinflusst den gesamten Vorgang der Bestrah-
lungsplanung bis hin zur eigentlichen Behandlung. Diese Dissertation befasst sich mit der
Evaluierung und Verbesserung von speziellen Techniken zur Kompensation der Atembe-
weglichkeit bei SBRT in einem klinischen Umfeld. In den klinischen Abläufen am Klinikum
der Universität München waren zu Beginn der Arbeiten dieser Dissertation Verbesserun-
gen nötig: Der damalige Einsatz des sogenannten 4DCTs (Englisch: respiratory correlated
computed tomography), welches für die Behandlung mit SBRT dringend erforderlich ist,
wurde als unpraktisch und anfällig für Fehler in der Datenrekonstruktion betrachtet. Zum
zweiten musste die damalige Methodik der Bestrahlungsplanung bei atembeweglichen Tu-
moren evaluiert und verbessert werden. Außerdem sollte eine Atemtriggerungstechnik in
der Klinik implementiert werden, weshalb das neuartige System auf seine Eigenschaften
bezüglich getriggerter Bestrahlung hin untersucht werden musste.
Zuerst wurde das damalige 4DCT Rekonstruktionsschema untersucht, da die exak-
te Kenntnis des zeitlichen Verlaufs der Tumorposition vor der eigentlichen Behandlung
bei stereotaktischen Bestrahlungskonzepten im Lungenbereich essentiell ist. Mit Hilfe des
4DCTs kann patienten-individuell die gesamte Tumorbeweglichkeit erfasst werden. Jedoch
können einige 4DCT Rekonstruktionsalgorithmen die Tumorbeweglichkeit über- oder auch
unterschätzen: Entweder durch Ungenauigkeiten in der Datenakquise oder durch falsche
Zuordnung der CT Schichten zu den verschiedenen Atemphasen. Der bisherige klinische
Arbeitsablauf, eine zyklusbasierte Sortierung der Atemkurve ohne zuverlässige Detekti-
on der maximalen Inspiration (dem Startpunkt von jedem Zyklus) war von derartigen
Fehlerquellen beeinflussbar. Deshalb wurde sowohl eine zyklusbasierte Sortierungsmetho-
de mit akkurater Detektion der Maxima als auch die sogenannte lokal amplitudenbasierte
Sortierung (LAS) zur Reduktion von Bildartefakten und Verbesserung der 4DCT Qua-
lität implementiert. Sowohl in einer Phantomstudie mit 10 verschiedenen Atemkurven, als
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auch in einer Patientenstudie (10 Patienten) sind die drei verschiedenen 4DCT Phasen-
Zuordnungsalgorithmen verglichen worden. Beide neu implementierten Verfahren redu-
zierten den Fehler in der Rekonstruktion des Tumorvolumens im Vergleich zur bisherigen,
zyklusbasierten Methode (ohne korrekte Detektion der Maxima) am Phantom sowie bei
der Patientenstudie. Wegen der geringeren Praktikabilität des LAS Ansatzes auf Grund
verschiedener manueller Eingriffe in klinische Systeme war die LAS Methode trotz ver-
besserter 4DCT Rekonstruktion nicht empfehlenswert. Jedoch wurde der zyklusbasierte
Ansatz mit optimaler Detektion der Maxima der Atemkurve wegen seiner geringeren Feh-
lerabhängigkeit für den klinischen Einsatz empfohlen.
Im zweiten Teil der Arbeit war festzustellen, welcher CT Datensatz die genaueste
Grundlage für die klinische Bestrahlungsplanung bei SBRT Behandlungen darstellt. Des-
halb wurde ein 4D Dosisevaluierungs-Tool implementiert, welches die tatsächliche Atmung
des Patienten während der Bestrahlung mit dem Log Datensatz des Linearbeschleuingers
(LINAC) kombiniert, um 4D Monte Carlo Dosisberechnungen auszuführen. Die Grundla-
ge hierbei ist die Dosisberechnung auf vier verschiedenen CT Datensätzen: einem nativen
3DCT Datensatz in freier Atmung, ein aus dem 4DCT erstelltem AIP (Englisch: average
intensity projection, ein CT Datensatz mit der mittleren Elektronendichte aller 4DCT Pha-
sen) und einem MIP Datensatz (Englisch: maximum intensity projection, ein CT Datensatz
mit der maximalen Elektronendichte aller 4DCT Phasen), sowie Dichteüberschreibungen
(DO) in einem 3DCT. Die 4D Dosis wurde auf den einzelnen 4DCT Atemphasen gemäß der
Atemkurve der Patienten nachgerechnet und mittels deformierbarer Registrierung auf das
GTV (Englisch: Gross Tumor Volume) in maximaler Expiration akkumuliert. Obwohl die
geringsten Unterschiede zwischen geplanter und 4D-nachgerechneter Dosis bei AIP- und
MIP-basierter Bestrahlungsplanung ermittelt wurden, weisen die Resultate auf eine starke
Abhängigkeit mit der individuellen Tumorbeweglichkeit, der Variabilität der Atmungsbe-
wegung im Allgemeinen und der Tumorgröße hin. Durch die erstmalige Kombination von
patientenindividueller Atembeweglichkeit während jeder Fraktion einer SBRT Behandlung
und 4D Monte Carlo Dosisberechnung auf Basis der Log Datensätze des LINACs lässt sich
eine gute Approximation der tatsächlich applizierten Dosis gewährleisten.
Zuletzt mussten die technischen Charakteristika bei der Kombination eines LINACs
mit einem Surrogat zur Messung der Atembeweglichkeit bekannt sein, um eine präzise und
akkurate Behandlung mit Atemtriggerungstechniken (dem sogenannten ”Gating”) zu ga-
rantieren. Die Genauigkeit der Dosisapplikation und die Latenz eines Oberflächenscanners,
welcher zur Triggerung eines LINACs benutzt wird wurden mit Hilfe eines dynamischen
Atemphantoms untersucht. Messungen mit einem statischen 2D-Dioden Array ergaben
einen Dosisunterschied zwischen getriggerter und ungetriggerter Bestrahlung von weniger
als 1% für klinisch relevante Gatingfenster von ca. 30%. Bei der radiographischen Film-
messung der Latenz beim Einschaltvorgang des Systems wurden Zeitverzögerungen bis zu
851ms± 100ms ermittelt. Sobald diese Parameter bekannt sind, könnte ein vorher definier-
tes Gatingfenster oder auch die Erweiterung des Sicherheitssaums des sog. Internal Target
Volume (ITV) angepasst werden.
Zusammenfassung xvii
Die Herausforderungen bei Bestrahlung von Lungentumoren mit SBRT beschränken
sich nicht ausschließlich auf die in dieser Arbeit behandelten Themen, besonders wegen
des hoch patienten-spezifischen Charakters respiratorischer Tumorbewegungen. Nichtsde-
stotrotz konnten die Ergebnisse dieser Dissertation die klinischen Arbeitsabläufe bei der
Behandlung von Läsionen in der Lunge mit den Mitteln der Strahlentherapie optimieren.
Das Ziel bei weiteren Studien ist die Evaluierung der tatsächlichen 4D Dosis mit akkurater,
verbesserter 4D Bildgebung und hoch spezialisierten Dosisapplikationsverfahren (wie z.B.
Atemtriggerung), was ein Potential zur weiteren (sicheren) Reduktion des zu bestrahlen-
den Volumens bei einer gleichzeitig verbesserten Schonung von gesunden Risikoorganen bei
SBRT Behandlungen zur Folge hat, ohne dass die Zielvolumensdosis verringert wird.
xviii Zusammenfassung
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Chapter 2
Introduction
With an estimated number of 18.1 million new cases worldwide and 9.6 million deaths in
2018 [11], cancer is among the leading causes of death in the 21st century. With rapidly
growing incidence and mortality rates, the struggle against cancer is a worldwide challenge
in modern medicine. As the most common cancer in men and the third most common in
women, lung cancer remains the most frequent cancer worldwide with around 2.1 million
new cases and around 1.8 million predicted deaths in 2018 [1, 11]. Four major histological
types of lung cancer exist: small cell carcinoma and three types of non-small cell lung
cancer (NSCLC) (adenocarcinoma, squamous cell carcinoma, and large cell carcinoma).
The best overall survival rate for NSCLC patients is achieved by surgical lobectomy and
systematic mediastinal lymph node dissection, but for about 20% of all patients diagnosed
with NSCLC surgery is not an option [23].
Best supportive care or conventionally fractionated radiotherapy were the remaining
choices until the introduction of stereotactic body radiation therapy (SBRT). In general,
radiation therapy uses high radiation doses to kill malignant tumor cells while trying to
spare radiosensitive organs in the proximity of the tumor (so-called organs-at-risk (OARs)).
SBRT can be considered as hypofractionated (meaning that the dose is delivered in less
fractions than in conventional radiation therapy with a higher dose per fraction in order
to achieve the same biological effect) high precision conformal radiation therapy to small
targets [9]. For medically inoperable NSCLC (stage I) patients, SBRT has been reported
to have local tumor control rates of 84-98% [23].
In general, SBRT faces a multitude of problems and challenges in addition to the uncer-
tainties and possible pitfalls of conventionally fractionated radiotherapy. One of the main
challenges in SBRT is the presence of respiratory motion. Considerable uncertainties in
SBRT treatments of thoracic and upper abdominal sites remain due to respiratory motion
[69]. Lung tumors move intra- and interfractionally according to the highly patient-specific
breathing motion. Increasing the treatment margins could account for these motions on
the one hand, but would also increase the dose to normal, healthy tissue on the other
[31]. These problems affect the whole radiation therapy treatment chain, from image ac-
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quisition over the course of treatment planning up to radiation delivery itself. Several
techniques are already applied for the management of respiratory motion in radiation ther-
apy, in order to reduce the dose to critical OARs. These include motion encompassing
methods, respiratory gated or breath-hold techniques, forced shallow breathing methods,
or respiration-synchronized delivery (”tumor tracking”).
The main goal of this thesis was to optimize the present workflows for SBRT at the
Department of Radiation Oncology of the LMU University hospital. The clinical need for
improvement led to the optimization of three different, clinically relevant tasks. Specifically,
three key issues are addressed in this thesis:
1. 4DCT reconstruction: Respiratory motion of anatomical structures deteriorates
the image quality of X-ray computed tomography (CT) of thoracic and upper ab-
dominal sites [22]. For SBRT treatment planning, the acquisition of 4DCT datasets
reduces artifacts which can occur in regular 3DCT datasets due to respiratory
motion and allows for an investigation of the full tumor breathing motion trace
[18, 22, 30, 36, 39]. Yet, there are differences between the methods of 4DCT acqui-
sition, with some being prone to artifacts and others influencing the depicted tumor
volume. With the regular, clinically used workflow for 4DCT acquisition and recon-
struction, the full tumor motion range could have been over- or underestimated. This
would influence the whole treatment planning process from target delineation to valid
dose calculation at the available treatment planning CT scanner (Toshiba Aquilion
16 Large Bore, Toshiba Medical Systems Corporation, Otawara, Japan). Therefore,
the task was to establish and optimize different workflows using an optical surface
scanner as a motion monitoring system. In addition, the influence of different image
sorting algorithms for 4DCT image reconstruction is evaluated in a phantom and a
patient study to devise recommendations for clinical use.
2. 4D treatment planning: The dose applied to the patient is usually calculated
based on 3DCT dataset. As tumors in thoracic and abdominal treatment sites move
due to respiratory motion, dose differences between planned and actually delivered
dose in the target region and additionally in the surrounding OAR structures are
present in most clinical settings. In order to get a close approximation of the ”ground
truth” delivered dose to the moving tumor, the dose calculation has to be carried out
time-resolved. The goal was to develop a workflow for 4D MC dose calculation with
the actual patient breathing trace for 3D-CRT and VMAT treatment plans for each
individual treatment fraction. In addition, the question on which CT dataset treat-
ment planning has to be carried out, in order to minimize possible dose differences
between planned and delivered dose, is evaluated and discussed.
3. Respiratory Gating: Advanced techniques, such as respiratory gating or breathing
control, can increase the accuracy of dose delivery in anatomical sites affected by
respiratory motion [69]. As gated treatment (in which the dose is only delivered
during specific motion phases) has been introduced in radiation therapy, the dose
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to surrounding OARs structures can potentially be reduced to a minimum while
still guaranteeing optimal tumor coverage [34, 42]. A technique with such a high
potential in dose sparing has to be carried out with maximal accuracy and precision.
Therefore, the capability of modern medical LINACs for respiratory gating needs to
be assessed prior to clinical implementation. A novel surface imaging system has
been installed at the LMU university hospital in combination with a LINAC which
has not been designed specifically for the use in gated radiotherapy. For this specific
clinical setting, thorough validation tests regarding dosimetric accuracy and overall
system latency were designed and carried out.
.
Chapter 3 gives an overview of the technological and physical background of photon
radiation therapy, including high energy photon beam generation with modern medical
LINACs and the interaction of X-ray photon with matter. Chapter 4 describes the treat-
ment planning process from CT (and 4DCT) acquisition to target delineation, radiation
therapy treatment techniques (including dose calculation algorithms), and special require-
ments for SBRT treatment delivery. Chapter 5 summarizes the uncertainties in lung radi-
ation therapy and describes methods for uncertainty mitigation. The novel contributions
of this thesis are thereafter discussed in chapters 6, 7, and 8: In chapter 6, different phase
sorting algorithms for 4DCT reconstruction are compared and validated clinically, and a
novel phase sorting algorithm is introduced. In chapter 7, a workflow for the combination
of the actual patient breathing trace during each individual treatment fraction with the
Linac’s log file information for Monte Carlo 4D dose calculations has been established.
This has been tested on multiple CT datasets for lung SBRT treatment planning. In chap-
ter 8, the capabilities of a medical LINAC to perform gated treatments are characterized
in terms of system latency and dosimetric accuracy. In chapter 9, the conclusions of this
thesis and future perspectives are discussed.
6 Introduction
Chapter 3
Technological and Physical
Background of Photon Radiation
Therapy
Radiation therapy uses ionizing radiation to damage the desoxyribonucleic acid (DNA) of
malignant cancer cells, leading to tumor cell death or inactivation. Photons and charged
species such as electrons, protons, or heavier ions (to name the most widespread applied
species) can be utilized for radiation therapy. Cell damage occurs mainly direct for charged
particles and mainly indirect for photons through ionization of water, creating free radi-
cals such as H20
+ (water ion) or OH• (hydroxyl radical) which subsequently damage the
cancerous cell DNA, as the most radiation sensitive cell component.
The following chapter focuses on selected technical and physical aspects of radiation
therapy, specifically high energy photon beams generated with a medical linear accelera-
tor (LINAC) (so called photon external beam radiotherapy (EBRT)) and the interaction
of X-ray photons with matter. Other important branches of radiation therapy such as
brachytherapy or EBRT with charged particles or EBRT using gamma rays from radioac-
tive isotopes such as 60Co have not been adressed in this thesis and will therefore not
be described in the following chapter. Additional information on the physics of radiation
therapy can be found in [32, 33, 49, 56].
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3.1 The Medical Linear Accelerator
Modern medical LINACs are sophisticated machines featuring different operational sys-
tems, mainly consisting of a 360◦ rotating gantry, the gantry stand, a modulator cabinet,
the patient support assembly (e.g. the treatment table or patient positioning devices),
and a control console. Figure 3.1 shows an example of a modern LINAC used in radiation
therapy.
Figure 3.1: A modern medical linear accelerator (LINAC) [17] with the main components:
(1) rotating gantry, (2) gantry stand, (3) patient support assembly, and (4) collimator.
Medical LINACs accelerate electrons (produced in the injection system, the so-called
”electron gun”) in microwave radio frequency (RF) fields in a frequency range between
1 − 10GHz. The acceleration of these low energy electrons is carried out in the so-called
”waveguide” accelerator. The RF field in the waveguide is produced by the RF power
generation system (either a magnetron or a klystron). After acceleration, the electrons
are directed onto a high Z material target for Bremsstrahlung conversion in the treatment
head using bending magnets. This produces a photon beam in the direction of the LINAC
isocenter (the point in space where the LINAC gantry and collimator rotate around).
Figure 3.2 shows a schematic diagram of a typical modern medical LINAC with the essential
components described in the following sections.
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Figure 3.2: Scheme of a LINAC [49].
3.1.1 Injection System or ”Electron Gun”
An electrostatic accelerator, called ”electron gun”, serves as the source for low speed elec-
trons. It contains a heated filament cathode and a grounded anode. Heating of the cathode
to temperatures over 1000° C leads to thermionic electron emission. These electrons are
accelerated towards the perforated or gridded anode, through which they are inserted into
the LINAC waveguide.
3.1.2 Radiofrequency Power Generation System
The RF field in which the electrons are accelerated in the waveguide is produced in the RF
power generation system. The RF power source can either be a magnetron or a klystron,
which both use electron acceleration and deceleration in vacuum for the RF field generation.
The main difference between the two types is that a magnetron is a high power RF field
source, while a klystron is rather a power amplifier for microwaves generated by an RF
oscillator. A pulsed modulator produces the high voltage, high current and short duration
pulses required by the RF power source and the electron gun.
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3.1.3 Waveguide
The RF field is transmitted into the waveguide for acceleration of the electrons which
enter from the electron gun. Waveguides are evacuated metallic structures containing
rectangular or circular cross-sections. Modern waveguides can be divided into two types:
Traveling wave structure waveguides, in which microwaves enter on the side of the electron
gun and propagate towards the high energy end. The microwaves are either absorbed
without reflection, absorbed into a resistive load, or fed beck into the waveguide input
end. With standing wave structure types, a conducting disk is placed at the ends of
the waveguide, where the RF power is reflected, leading to a standing wave. Standing
waveguides usually are more efficient, because every second cavity carries an electric field,
while in a traveling wave configuration, only every fourth cavity is suitable for electron
acceleration. Therefore the length of a LINAC waveguide with standing wave structure
can be reduced by 50% while maintaining the same energy.
Figure 3.3: Simplified layouts of a traveling waveguide (a) and a standing waveguide
(b), adapted from Zhu and Wang [73]. The red spots show electron bunches and the
electric field distributions along the waveguide are displayed underneath the layout. In
the traveling wave structure (a), the arrow shows the direction of the electric field on the
electron bunches with the polarity on the cavity walls. The arrows in the standing wave
structure layout (b) show the negative electric field direction at timepoints t1 and t2.
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3.1.4 Electron Beam Transport
After the accelerated electron beam exits the waveguide, a bending magnet is needed to
direct the beam towards the isocenter (for conventional LINACs). There are three different
electron bending systems: 90◦ bending, achromatic 270◦ bending, or slalom 112.5◦ bending.
Usage of the 90◦ bending system has become obsolete for medical LINACs as electrons of
different energies will be bended in various ways using this type of configuration, so either
achromatic or slalom bending systems along with steering and focusing coils are used for
the generation of a focused electron beam.
Figure 3.4: Three different types of achromatic focusing bending magnets: a) 270◦, b)
90◦ [73], and c) slalom 112.5◦ [20]
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3.1.5 Treatment Head
Figure 3.5: The process of photon beam
generation from an electron beam in the
treatment head [28].
The focused and aligned electron beam
is then brought into the treatment head,
which mainly consists of one or more re-
tractable X-ray targets, flattening and scat-
tering filters, a fixed primary and an ad-
justable collimator, and ionization cham-
bers. When the electrons collide with the
X-ray target of high-Z material (e.g. tung-
sten), Bremsstrahlung and characteristic X-
rays are produced. The resulting maxi-
mum energy of the X-ray energy spectrum
equals the incident electron energy due to
Bremsstrahlung interactions.
A primary collimator assembly is located di-
rectly below the target and confines the pho-
ton beam into a cone-shaped beam and de-
fines the maximum field size of the LINAC.
It is followed by a scattering foil and a flat-
tening filter, which create a uniform flat
beam profile with reduced scattering. For
higher dose rates and therefore faster treat-
ment times, the flattening filter can be re-
moved (in combination with modern fluence
modulating techniques). The dose rate,
beam symmetry, and beam homogeneity are
continuously monitored during dose delivery
in the treatment head using segmented ion-
ization chambers. Below these chambers are
two or four secondary (movable) beam defin-
ing collimators, often referred to as ”jaws”. A schematic overview of the components in
the LINAC treatment head and the process of photon beam generation from an electron
beam can be found in figure 3.5. In modern medical LINACs, the second pair of jaws is
usually replaced by a MLC (see an example in figure 3.6), with up to 160 leaves (80 leaf
pairs) and field sizes of up to 40x40 cm2 to spatially vary the beam shape.
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Figure 3.6: Image of a modern MLC with 80 leaf pairs for the creation of various field
shapes and sizes [16].
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3.2 Interaction of X-ray Photons with Matter
The photon beam produced by the LINAC is characterized in terms of photon fluence and
energy fluence. The photon fluence Φ (which may also be used to describe charged particle
beams as particle fluence) is defined as the quotient dN by dA, with dN as the number of
photons entering an imaginary sphere of a cross-sectional unit area dA.
Φ =
dN
dA
(3.1)
Energy fluence Ψ is defined as the quotient of dE by dA, where dE is the radiant energy
on a sphere of cross-sectional unit area dA.
Ψ =
dE
dA
(3.2)
Energy fluence can be calculated from photon fluence (assuming a monoenergetic beam)
using:
Ψ =
dN
dA
E = ΦE (3.3)
The photon fluence is inversely proportional to the square of the distance from the
photon beam point source, which describes the photon beam propagating through vacuum
(inverse square law), neglecting attenuation in air. When the photon beam enters any
medium, it is not only affected by the inverse square law. Absorption and scattering inside
the medium (e.g. the patient or a phantom) also affect the photon beam. The number
of photons dN reduced by an absorber medium is proportional to the number of incident
photons N and the thickness of the absorbing material dx. This can be described as:
dN = −µNdX (3.4)
with µ being the attenuation coefficient. This differential equation for attenuation can
be solved in terms of intensity, where I(x) is the intensity transmitted through a thickness
x and I0 is the initial intensity impinging onto the absorber medium.
I(x) = I0e
−µx (3.5)
In general, the attenuation coefficient µ depends on the photon energy and character-
istics of the medium. The number of photons decreases with the absorber thickness. With
µ depending on the density of the material, an independence of density can be achieved
by division of µ with the density ρ, resulting in the mass attenuation coefficient µ
ρ
which is
now only dependent on the atomic composition of the medium, specifically the attenuator
atomic number Z. Figure 3.7 shows the dominance of the three major photon interaction
forms (photoelectric effect, Compton effect, and pair production) relative to the atomic
number Z in a wide energy range of relevance for diagnostics and therapy.
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Figure 3.7: Relative predominance of the three major types of photon interaction with
matter: Photoelectric effect at low photon energies, Compton effect at intermediate ener-
gies, and pair production at high energies. Both curves indicate regions of atomic number
and photon energy, where the neighboring effects are equally probable [49].
The photon beam produced by medical LINACs can be attenuated by five major types
of interactions with matter: Photonuclear reactions (1), the reactions between the photons
and the nucleus, are important only for photon energies approximately > 10MeV. In
three processes, photons interact with the atomic shell: coherent (Rayleigh) scattering (2),
photoelectric effect (3), and Compton effect (incoherent scattering) (4). In the Coulomb
field of the nucleus pair production can occur for for energies > 1.022MeV, as well as triplet
production in the Coulomb field of the atomic electrons for energies > 2.044MeV (5). The
resulting total mass attenuation coefficient as the sum of all individual coefficients for the
above-mentioned processes neglecting photonuclear reactions can be denoted as:
or triplet production
µ/ρ = σcoh/ρ+ τ/ρ+ σc/ρ+ κ/ρ (3.6)
with attenuation coefficients σcoh, τ , σc, and κ for coherent scattering, photoelectric
effect, Compton scattering, and pair production, respectively. Figure 3.8 shows the total
mass attenuation coefficients and the individual coefficients for monoenergetic photons in
water and lead.
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Figure 3.8: Total and partial mass attenuation coefficients for monoenergetic photons in
water (left) and lead (right) [54].
3.2.1 Photonuclear Reactions (Photodisintegration)
A photon can directly interact with the atomic nucleus through its electromagnetic char-
acteristics, which is called photonuclear reactions or photodisintegration (for a schematic
representation see figure 3.9). The energy of the incident photon is absorbed by the nu-
cleus, leading to an excitation. Above a certain threshold energy the excitation energy can
lead to an emission of one or more nucleons. For most elements, this threshold energy is in
the range between 6MeV and about 20MeV. In radiation protection, this effect has to be
accounted for, because activation of air, certain materials, or the patient can occur when
using photon beam energies above 10MeV. In addition, a not negligible neutron flux can
result at high radiation intensities.
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Figure 3.9: Schematic representation of a photonuclear reaction. Through photon ab-
sorption the atomic nucleus is excited, which leads to an emission of one or more nucleons
(right side) [33].
3.2.2 Coherent (Rayleigh) Scattering
Figure 3.10: Schematic representation of
coherent or Rayleigh scattering. The inci-
dent photon excites the electron hull to oscil-
lations. The scattered photon has the same
energy as the incident photon, but usually a
different direction [33].
Coherent scattering, which is also known as
classical or Rayleigh scattering, is the pro-
cess of an electromagnetic wave passing near
a strongly bound electron causing the elec-
tron to oscillate. Energy with the same fre-
quency as the incident wave is radiated from
the oscillating electron, without any changes
in energy or absorption by the medium. The
wavelength of the emitted electromagnetic
wave is equal to the wavelength of the in-
cident wave. The attenuation coefficient for
coherent scattering σcoh above 10 keV is pro-
portional to the atomic number of the ab-
sorber atomic number Z and the absorber
material density ρ:
σcoh ∝ ρ ·
Z2.5
A · E2γ
≈ ρ · Z
1.5
E2γ
(3.7)
For clinical photon radiation therapy, co-
herent scattering can be neglected as no en-
ergy transfer is involved, the scattering ef-
fect is negligible, and it is only probable in materials with high atomic numbers and for
low energy photons (< 100 keV) [32, 33].
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3.2.3 Photoelectric Effect
A photon can also interact with a tightly bound orbital electron of an inner shell (preferen-
tially the K or L shell), where the energy of the incident photon hν is absorbed by the atom
and transferred to an electron of the atom. This phenomenon is called the photoelectric
effect. The emitted electron (”photoelectron”) has a kinetic energy Ekin = hν − EB, with
EB as the binding energy of the electron. As the electron is emitted, the vacancy in the
atomic shell has to be filled by an electron in one of the outer shells under the emission
of characteristic X-rays. Another alternative is the emission of monoenergetic so-called
Auger electrons or secondary emitted electrons to which the energy has been transferred.
Figure 3.11 shows a schematic representation of the photoelectric effect with characteristic
X-ray emission.
Figure 3.11: Schematic representation the photoelectric effect (occuring on an electron
of the K shell). The atomic shell is ionized through absorption of the incident photon
(left) and the vacancy in the atomic shell is filled with an electron from an outer shell
(right). The remaining energy is emitted as a characteristic photon (or a cascade of Auger
electrons) [33].
The photoelectric attenuation coefficient τ describes the probability per unit path
length for photoelectric absorption and is directly proportional to the density ρ and in-
creases with the atomic number (∝ Zn). The exponent of the atomic number n has a value
of n ≈ 4 for high atomic numbers and n ≈ 4.5 for low atomic values [33].
τ ∝ ρ · Z
n
A
≈ ρ · Z
4-4.5
A
(n = 4-4.5) (3.8)
The angular distribution of photoelectrons is dependent on the the photon energy. For
higher energies, more photons are emitted forward [32, 33].
3.2. Interaction of X-ray Photons with Matter 19
3.2.4 Compton Effect (Incoherent Scattering)
Figure 3.12: Schematic representation of
the Compton effect as an inelastic interaction
between an incident photon and a weakly
bound hull electron [33].
The Compton effect describes an inelas-
tic interaction of a photon with an elec-
tron in the outer shell, which is bound
weakly (”free”). An electron is consid-
ered ”free” or ”quasi-free”, when the en-
ergy of the incident photon Eγ0 is much
higher than the binding energy of the elec-
tron. The photon energy and its mo-
mentum p⃗γ0 are partially transferred to
the electron. When the photon and
the electron collide, the photon is scat-
tered under an angle φ while the elec-
tron is ejected from the atomic shell un-
der an angle θ, which leaves the shell ion-
ized.
The remaining energy of the scattered
photon E
′
γ is calculated applying the laws
of conservation of energy and momentum as a function of the incident photon energy Eγ0
and the photon scattering angle φ, with E0 = m0c
2 = 511 keV:
E
′
γ =
Eγ
1 + Eγ
m0c2
· (1− cosφ)
(3.9)
The change in photon wavelength ∆λ can be derived using the Compton wavelength
λC =
h
mec
as:
∆λ = λC(1− cosφ) (3.10)
The energy transferred to the electron Ekin is calculated from the difference of the
remaining photon energy after scattering E
′
γ and the incident photon energy Eγ0, with a
negligible binding energy EB as the electron is considered ”free” :
Ekin = Eγ0 − E
′
γ − EB ≈ Eγ0 − E
′
γ (3.11)
The energy dependence of the attenuation coefficient for the Compton effect σc for
energies between 0.2MeV and 10MeV (which is the energy range the Compton effect
occurs in most materials) can be described as:
σc ∝ ρ ·
Z
A
· 1
Eγ
(3.12)
The Compton effect is the dominant photon interaction process in human soft tissue
and other materials with low atomic number Z for photon beam energies between 30 keV
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and 30MeV and therefore the main effect of beam attenuation in external beam radiation
therapy using photons [32, 33].
3.2.5 Pair Production
Photons can also interact with the electrical field of charged particles, such as the atomic
nucleus or electrons. If the photon energy exceeds the energy-mass-equivalent for electrons
(2m0c
2 = 2 · 511 keV= 1.022MeV) the photon can disappear completely in the strong
Coulomb field of atomic nuclei and an electron-positron pair with a maximum energy of
Ekin = Eγ − 1.022MeV is produced. This process is referred to as pair production. The
probability of pair production per unit path length κ increases logarithmically with the
photon energy Eγ and proportionally with Z for light and medium-weight elements [33]:
κpairproduction ∝ Z · ρ · logEγ | Eγ > 1.022MeV (3.13)
The incident photon kinetic energy is divided between between the rest mass energy
and the kinetic energy of the electron–positron pair. It can be distributed in any available
way to electron and positron for large photon energy, although the most probable distri-
bution is half the available kinetic energy on each particle. Positron and electron move
throughout the absorber medium and deposit energy in small portions in Coulomb excita-
tion and ionization with the atomic electrons of the absorber. Once the positron comes to
rest, it recombines with a shell electron of the absorber under emission of two annihilation
photons (each having 511 keV energy).
If pair production occurs in the field of an orbital electron, three particles share the
incident photon energy with a threshold of 4m0c
2 = 2.044MeV. This process is know as
triplet production [32, 33].
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Figure 3.13: Schematic representation of pair (left) and triple production (right). The
resulting pair consists of an electron and a positron [33].
3.2.6 Energy Transfer and Absorbed Dose
Compton effect, pair production, and photoelectric effect all lead to an energy transfer
(complete or partial) from photons to secondary charged particles (electrons). This energy
transfer for ionizing uncharged particles is described by the term kinetic energy released per
unit mass (KERMA), K, as the quotient of dϵtr, the mean sum of all initial kinetic energies
of the charged ionizing particles liberated in a mass dm of a medium by the uncharged
particles incident on dm [2]:
K =
dϵtr
dm
(3.14)
For a photon beam, KERMA is directly proportional to the photon energy fluence Ψ:
K = Ψ(
µtr
ρ
) (3.15)
µtr
ρ
denotes the spectrum averaged mass energy transfer coefficient of the medium, which
is less dependent on the density of the absorber. The mass energy transfer coefficient is
defined as:
µtr
ρ
=
∑︂
j
fj
µj
ρ
= f
µ
ρ
(3.16)
fj denotes the average fraction of photon energy that is transferred to kinetic energy
of charged particles in interactions of type j, f being the average of fj, and
µ
ρ
the mass
attenuation coefficient [59].
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Ameasure for the quantification of deposed energy is absorbed dose D as the expectation
value of imparted energy dϵ per mass unit dm.
D =
dϵ
dm
=
1
ρ
dϵ
dV
(3.17)
The unit of measure for absorbed dose is gray (Gy = J · kg−1). Energy is imparted in
matter for indirectly ionizing radiation by energy transfer to secondary charged particles,
which results in KERMA. Secondly, the kinetic energy from these charged particles is
partially transferred to the medium, which results in the absorbed dose, while some energy
is lost in the form of bremsstrahlung and annihilation in flight. The amount of KERMA
(energy transferred) from the photon beam to charged particles at a particular location
does not imply that the energy absorbed by the medium occurs at this same location,
due to the finite range of secondary electrons resulting from photon interactions besides
radiation losses.
When it comes to the irradiation of tumors or lesions in the lung region, the mass dm of
the surrounding tissue (which can be approximated as air) is relatively low. With the same
amount of energy transferred, KERMA increases, but the absorbed dose is decreased.
Chapter 4
Modern Photon Therapy and
Treatment Planning
The complete process of modern radiation therapy can be described using the so-called
”chain of radiotherapy”[10, 55]. At first, the patient needs to be immobilized reliably and
exactly before initial imaging to guarantee a precise dose delivery over the course of the
whole treatment chain. Immobilization is mostly established using casts and moulds and
the degree of patient immobilization is always relative to the treatment type (e.g. the
highest need for correct and firm patient immobilization arises when using single-fraction
high-precision stereotactic irradiation). Subsequently, the imaging and tumor localiza-
tion process begins: using 3D imaging, the tumor (or lesion) and surrounding organs-at-
risk (OARs) can be determined for treatment planning. After delineation of the treatment
target(s) and the OARs, the dose is calculated and optimized and the resulting treatment
plans are visualized and evaluated using a treatment planning system (TPS). There are two
standard procedures available in modern radiation therapy clinics. In three-dimensional
conformal radiation therapy (3D-CRT) the treatment machine parameters (geometric and
dosimetric) are evaluated in a trial and error process, in search of the most adequate
beam directions, field shapes and resulting dose from each individual field. In contrast to
this manual forward planning approach, inverse planning for intensity modulated radia-
tion therapy (IMRT) techniques uses predefined treatment goals for the determination of
treatment machine parameters. The TPS uses these treatment goals as an input for an
automated optimization of a certain treatment plan. The final treatment plan is evalu-
ated by medical physicists physicians in terms of target volume dose coverage and dose to
OARs. In addition, the 3D dose distributions among relevant regions of interest (ROIs)
are reduced to the form of a dose-volume histogram (DVH), where the plan quality can be
evaluated using simplified measures in a graphical 2D format.
Patient positioning during treatment includes the same set-up devices used for immo-
bilization during imaging, as all characteristics of these device must be known throughout
the treatment planning process. In addition, the correct patient position at the LINAC
is nowadays ensured using image guided radiation therapy (IGRT), where the current
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position is assessed with respect to planned position to perform corrections using two-
dimensional (2D), 3D, or even 4D imaging techniques. In the past years, surface guid-
ance was also established as a possible way of patient positioning during initial imaging
and treatment. The actual dose delivery with modern medical LINACs using photons
or electrons has been described in the previous chapter. Quality assurance and quality
management in radiation therapy is a crucial step in the treatment process chain as all
steps and all links are subject to various inaccuracies and possible errors. Minimization of
these potential errors can only be ensured with a full quality management system including
dosimetry checks, hardware and software test, and full documentation and standardization
of all processes. More details on the ”chain of radiotherapy” can be found in Brady et al.
[10].
Figure 4.1: The chain of radiotherapy [10]
The following chapter describes the processes of medical image acquisition for radiation
therapy. For the studies performed in this thesis, X-ray computed tomography (CT) was
the main source of medical images.
Other image acquisition methods that are already in use in radiation therapy help to
gain further information on tumor type and localization, e.g. positron-emission tomog-
raphy (PET) and magnetic resonance imaging (MRI). As these modalities have little
influence on the studies performed, they will not be described in detail in this thesis. As
surface imaging was one of the key features for all investigations, one section will give a
brief overview of modern systems for surface-guided radiation therapy (SGRT).
Secondly, an overview of radiation therapy treatment techniques (including the process
of target definition) from simple 2D to 3D intensity-modulated techniques and so-called
stereotactic body radiation therapy (SBRT) will be given.
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4.1 Medical Image Acquisition for Radiation Therapy
4.1.1 X-ray Computed Tomography
For radiation therapy, the acquisition of X-ray computed tomography (CT) images does
not only play a fundamental role in tumor identification, localization, and delineation.
The second major part is the use of CT in treatment planning, especially for a quantita-
tive characterization of the physical properties of heterogeneous tissue in terms of electron
densities for dose calculation [10]. X-ray computed tomography (CT) imaging results in
the production of several axial slices representing the X-ray attenuation characteristics of
tissue, providing 3D information of the patient’s anatomy with high contrast and resolu-
tion, based on the tissue electron density for tissues with considerable differences in their
individual attenuation properties. The 3D information is acquired by translating the couch
through the CT gantry. Simplified, an X-ray source (tube) is rotating around the patient,
in which the X-rays are attenuated and then measured by an X-ray detector, which consists
of about 105 channels per slice. Modern CT detectors consist of a scintillator crystal in
combination with a photodiode [56]. The detector measures the beam intensity I according
to:
I = I0e
−
∫︁
S µ(x)dx (4.1)
with I0 being the beam intensity before entering the medium for a beam of single-energy
photons traveling through a inhomogeneous medium along a straight line S, with a linear
attenuation coefficient µ(x). As in reality X-rays are polychromatic, equation 4.1 can be
used as an approximation for a monochromatic beam. For a set of measured projection
values p(L), the negative logarithm of each intensity measurement along a line corresponds
to the line integral along the line L of an object’s linear attenuation coefficient distribution
µ(x, y, z) :
p(L) = −lnI(L)
I0
=
∫︂
L
dLµ(x, y, z) (4.2)
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Figure 4.2: Schematic representation of a clinical CT acquisition. Left: The X-ray
photon attenuation is measured in the detector array along straight lines. Right: In order
to gain enough information for 3D image reconstruction, a large number of line integrals
are measured during the CT gantry rotation[10].
Figure 4.3: Ranges of CT HU for cer-
tain organs[10].
With enough information gathered from mul-
tiple measurement angles, the projection values
p(L) can be used for image reconstruction. For
single slice CT scanners (at a fixed table posi-
tion) this would just be the convolution of all
projection data with a reconstruction kernel and
the backprojection into the image domain, which
is called filtered backprojection [10]. Image re-
construction for spiral CT scanners (with a con-
tinuously rotating gantry and the patient mov-
ing through the gantry with constant speed), re-
quires z-interpolation as an additional reconstruc-
tion step. Virtual scan data corresponding to a
circular scan at the desired reconstruction plane
is synthesized before obtaining the final image
via filtered backprojection. The result is a re-
constructed image f(x, y, z) and is represented by the individual tissue attenuation values
normalized to the Houndsfield scale: Air with zero attenuation is given a value of -1000HU
and water with an attenuation of µwater as 0HU. The CT attenuation value µ for the in-
dividual tissue electron density can therefore be represented by CT values:
CT =
µ− µwater
µwater
· 1000HU (4.3)
A CT value of any voxel in the reconstructed 3D image dataset is directly related to
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the attenuation values (which are proportional to the material density), therefore one can
interpret the CT value as the density of the object at this certain location. The main
difference between a standard, radiological CT and a CT used for radiation therapy treat-
ment planning is the correct relationship between CT values and the electron densities,
as tissue heterogeneities have to be considered precisely [57]. This results in a so-called
planning CT for the treatment process.
CT volume datasets can be acquired in two different scanning modes: circular scan-
ning, also known as axial CT scanning, where a number of consecutive slices are scanned
using circular tube-detector rotations with small table shifts. More widely used nowadays
is helical or spiral scanning, where the X-ray tube is in constant rotation around the patient
translated continuously through the CT gantry. For increased acquisition speed, modern
CT scanners use multiple detector rows in the detector array for the acquisition of multiple
slices per rotation, which presents new challenges in image reconstruction. This is called
multi-slice CT.
4.1.2 Four-dimensional Computed Tomography
In radiation therapy of tumors or lesions in the thoracic and upper abdominal region, the
knowledge of tumor motion with respect to the patient’s natural breathing motion be-
comes inevitable and considerable uncertainties still remain due to respiratory motion [69].
Image quality in 3DCT scanning can be deteriorated due to respiratory motion [22] and cor-
rect treatment delivery can be challenging. Respiratory-correlated computed tomography
(4DCT) is a method, where time-resolution is introduced as a fourth dimension. 4DCTs
reduce breathing induced motion artifacts or distortions - which can occur in ”static”
3DCT scans - and allow for detailed investigation of tumor movement with regards to time
[18, 22, 30, 36, 39]. Although motion could be deducted from the raw CT data, a certain
type of surrogate signal helps in sorting the acquired oversampled CT raw dataset into
multiple datasets, so-called 4DCT phases to depict the maximum motion amplitude. The
4DCT dataset is usually split into phases of 10% or 5% of the breathing cycle, with the
0% being the maximum inspiration or end-of-inhale (EOI) breathing phase by convention.
4DCT Acquisition Methods: Spiral and helical
4DCT scans are collected over multiple breathing cycles either in spiral mode, where the
patient breathing curve is recorded and each reconstructed slice is assigned to a certain
breathing phase [18, 67], or an oversampled dataset of the raw CT data is acquired while
simultaneously recording the breathing curve using a surrogate breathing signal [30, 36, 39].
Using the patient breathing curve, the 4DCT breathing phases can be reconstructed from
the raw dataset. This is called the helical 4DCT acquisition mode.
28 Modern Photon Therapy and Treatment Planning
Figure 4.4: Coronal (top) and sagittal (bottom) slices as represented in a 3DCT (left
side) and the corresponding 4DCT phases (0% to 90% in 10% steps).
Phase Sorting Algorithms
There is a difference in the way the breathing curve is sampled for 4DCT reconstruction:
One can either user phase-based or amplitude-based sorting. In phase-based (or time-based)
sorting, a distinct point on the breathing curve (such as maximum inspiration or expira-
tion) is determined and the breathing curve is divided into equidistant sectors in between
two maxima or minima. The phased-based 4DCT technique has been used quite commonly
[18, 30, 36, 48] as it has been originally derived from 4D cardiac imaging [46]. More re-
cently, amplitude-based reconstruction methods, where the breathing phase is determined
by the amplitude of the breathing curve, were reported to have better image quality and
less motion artifacts [37, 71]. The importance of phase-based approaches have been re-
ported and discussed widely in current literature [3, 22, 35]. In chapter 6, we discuss a
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rather novel method of 4DCT sorting, the local amplitude-based sorting (LAS) approach,
that was developed and implemented as part of this thesis.
4.1.3 Surface Imaging
Surface imaging for radiation therapy, sometimes referred to as surface-guided radiation
therapy (SGRT), has been introduced into multiple clinics in the last decade. SGRT in
general is contactless and fast and can be used for patient positioning and intrafractional
motion monitoring. One of the obvious applications in the ”chain of radiotherapy” [55] is
patient positioning. Conventionally, the patient is positioned inside the treatment room ac-
cording to an in-room laser system with skin marks drawn directly on the patient to ensure
to same patient position as during CT acquisition. Using surface guidance the potential
advantages for daily patient positioning are increased accuracy within body regions, where
no skin marks are drawn on. The advantages of SGRT for patient positioning, especially
for tumors with superficial location, were evaluated in [8, 12, 47].
Intrafractional motion monitoring has been proven to be the second successful application
of SGRT. When monitoring the patient surface throughout the entire treatment fraction,
one can determine intrafractional shifts and account for them in a quick and reproducible
way by registering the ”live” patient surface to the planned surface. As the patient is
not immobilized on the treatment table in a traditional way and interfractional motion
could therefore increase, an interconnection between the optical surface scanner and the
LINAC can interrupt the treatment beam once patient movements outside of a certain pre-
determined threshold tolerance are detected. Additional information on surface guidance
for intrafractional motion monitoring can be found for example in Reitz et al. [51].
In addition, several special techniques, such as deep-inspiration breath-hold (DIBH) or
whole brain radiation therapy (WBRT) using open masks or even stereotactic radio-
surgery (SRS) can be performed with the help of surface imaging. Optical surface scanners
can also be used for the previously described 4DCT imaging technique (see section 4.1.2) to
measure the chest or abdominal movement as a surrogate for breathing motion. For DIBH
techniques, where the patient is treated in deep inspiration in order to either separate
OARs geometrically from the irradiated volume (e.g. the heart from the patient breast in
breast radiation therapy) or to minimize target motion, SGRT is nowadays widely used in
daily clinical routine [13, 58].
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Figure 4.5: A surface image of a patient upper body (green) and the corresponding
breathing curve measured at the location of the red spot in the surface image.
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4.2 Radiation Therapy Treatment Techniques
The following section gives an overview of the treatment planning process after the medical
image acquisition. Using the information from the planning CT, certain ROI structures
are defined: the tumor or lesion and the possible microscopic spread of malignant cells to
be irradiated in addition to all OARs near the tumor location. In addition to the plan-
ning CT, MRI and PET images also help in the tumor delineation process and are used
for target definition. As uncertainties are always present in radiotherapy (e.g. isocentric
deviations due to rotation of the LINAC gantry, collimator, table, or in-room imaging
devices), margins are added to the previously defined target(s) to ensure sufficient dose de-
livery or to OAR structures to meet certain dose criteria. The treatment plan is afterwards
generated in a treatment planning system (TPS) and dose distributions are evaluated by
physicians and medical physicists. The dose of a typical treatment plan is not irradiated
on the patient in one delivery, but rather distributed in fractions of the desired dose.
4.2.1 Target Definition
Target definition is a complex and broadly discussed subject. In general, a radiation oncolo-
gist outlines the volume to be irradiated in addition to all relevant OARs on the underlying
CT dataset. Information from multiple sources has to be taken into account for correct
target volume delineation, such as the results of radiological and clinical investigations,
tumor staging, surgical, histological, and pathological information, the patient’s history, or
the patient compliance for treatment. MRI also aids tumor delineation through the high
accuracy in visualization of anatomical structures with high soft tissue contrast. Using
radioactive tracers, functional imaging techniques such as PET and single-photon emission
computed tomography (SPECT) can visualize the tumor, because selected tracers have a
higher affinity for tumorous tissue with respect to normal tissue. Not only target definition,
but also OAR delineation needs to be carried out with high precision as a treatment plan
is evaluated not only by the target dose coverage, but also with respect to the dose sparing
to OARs [10].
Standard concepts and a standard nomenclature for target definition and delineation
have been specified in ICRU reports 50 [24] and 62 [25]: The gross tumor volume (GTV)
is the macroscopic (or gross) extent of the tumor and is determined using the CT and /or
MRI data in addition to other clinical or radiological investigations. Because of possible
surrounding microscopic tumor infiltration, the GTV has to be extended to a second vol-
ume, the clinical target volume (CTV) using an adjustable margin. Later on, the internal
target volume (ITV) can be applied to account for possible intrafractional physiological
organ or tumor movements (e.g. respiratory motion, pulsation, variable volume of rectum
or bladder, variations in tumor size or shape over the course of the treatment) [25]. An
ITV is difficult to define, if several GTV structures (e.g. delineated in all 4DCT phases)
are not available. Finally, another margin is added to the CTV or the ITV to account
for systematic and random errors and uncertainties in patient setup and beam adjustment
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Figure 4.6: Graphical representation [49] of the nomenclature for volumes of interest as
defined in ICRU reports 50 [24] and 62 [25].
to form the planning target volume (PTV). The dose is usually prescribed to the PTV
structure to ensure that the irradiated dose is delivered to GTV and CTV structures inside
the PTV [10].
4.2.2 From Two Dimensional to Three Dimensional Conformal
Radiation Therapy
After the announcement of the discovery of X-rays by Röntgen in 1895 [52], little time
passed for the first patient suffering from stomach cancer to be treated using X-rays in
1896 [15]. The development of reliable therapeutic equipment which can operate at 250-
400 kV for the treatment of superficial tumors took roughly 40 years after the discovery of
X-rays. Later on, Cobalt-60 radiation sources and betatrons were used for irradiation and
as a milestone in radiation therapy history replaced by the medical LINAC between 1960
and 1980. With operation at energies between 6-20MV, tumors deep inside the patient
could be gradually treated with higher precision and higher doses. CT based planning
(2D on one single CT slice) has been introduced at the end of the 1970s and replaced
the traditional way of 2D treatment planning with radiographic images and custom-made
blocks for blocking out parts of the rectangular-shaped beam. 3D computerized CT-based
treatment planning that uses LINACs is nowadays a standard procedure in every modern
radiation therapy department. Using the MLC, the rotating gantry, collimator, and table
as additional degrees of freedom, 3D treatment plans can be applied to the PTV with high
precision. 3D-CRT is the process of forward planning, meaning that beam directions, field
shapes and individual dose are designed manually and adjusted if clinical goals are not
fulfilled.
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4.2.3 Intensity Modulated Radiation Therapy Techniques
In contrast to forward planning approaches such as 3D-CRT, inverse planning is used
widely nowadays. Here, the machine parameters like beam shape and the desired fluence
(or intensity) per beam or field is not determined beforehand, but predefined treatment
plan goals, or so-called objectives are used as an input for a TPS in order for the TPS to au-
tomatically optimize a treatment plan fulfilling the given objectives. The goal of radiation
therapy plan optimization is the calculation of the LINAC parameters (e.g. beam angles,
shapes, or intensities) that fulfill the most criteria given as an input by the TPS, which can
be defined as the combination of the objective function and ”constraints”. While a con-
straint requires certain criteria to stay within predefined limits, if the criteria are defined
as an objective function (or parts of it), the maximization or minimization is desired [10].
The fluence modulation can be achieved in various ways in terms of dynamics: A static
approach is the pre-definition of certain gantry angles and a fluence modulation from each
gantry angle using the LINAC’s MLC. Each beam is decomposed into small segments and
the configuration of the MLC is changed after the irradiation of each segment. Therefore,
this technique is called ”step-and-shoot” IMRT. In addition, the pause (or step) between
each segment can be left out, leading to a dynamic technique with still pre-defined gantry
angles but a dynamical movement of the MLC with constant or variable dose rate (dynamic
multileaf collimator (DMLC)). The next step for dynamic (and therefore faster) dose de-
livery was the implementation of a moving gantry, rotating with variable gantry speed,
variable dose rate, and a dynamically moving MLC, called volumetric modulated arc ther-
apy (VMAT). In general, intensity modulated techniques have the advantage of similar or
better dose coverage and better conformality for various PTV forms, with less dose applied
to the OARs in contrast to 3D-CRT. This can be seen in an example in figure 4.7.
4.2.4 Biological Effects of Dose and Fractionation
The ionizing radiation applied during radiation therapy leads to cell DNA damage (as
briefly described in chapter 3). The relationship of absorbed dose and the fraction of
surviving cells can be described using models for cell survival. The often used linear
quadratic (LQ) model for the description of cell survival assumes two parameters as com-
ponents of cell kill: α, the parameter describing the initial cell survival curve slope (linked
to single interactions, such as mutations of genes vital to cell survival) and β describing
the quadratic component of cell killing (caused by two double strand breaks in one DNA
strand). S(D) as the fraction of cells surviving a dose D (applied in one single exposure)
can be described as:
S(D) = e−αD−βD
2
(4.4)
The ratio α/β describes the dose at which both linear and quadratic components of cell
killing are equal. Each cell type is affected by the same absorbed dose differently, which
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(a) 3D-CRT
(b) VMAT
Figure 4.7: Comparison of a 3D-CRT (a) and a VMAT (b) treatment plan for the same
target volume (red contour). The 95% isodose line (green) is covering the PTV (red)
in both cases, but with much higher conformality and lower dose applied to surrounding
tissue when using intensity modulated techniques.
can be referred to as the radiosensitivity of cells and tissue [49, 55].
The concept of applying dose in two or more parts over a period of days or weeks rather
than in one single session is called fractionation. A larger amount of dose must be applied
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to the patient to achieve the same biological effect, as sub-lethal radiation damages are
repaired during the breaks between the fractions. Cells with a low α/β ratio need more
total dose in a fractionated scheme to result in the same cell survival rate [10, 55]. The
biologically effective dose (BED) for the fractionation scheme can be defined using the
equal dose d of n fractions:
BED = nd(1 +
d
α/β
) (4.5)
Different schemes of fractionation with the same BED are considered isoeffective. The
effectiveness of fractionated radiation therapy is dependent of the α/β ratio. The main goal
of fractionation is a maximization of cell kill in the tumor in combination with maximal
sparing of dose to normal tissue [10, 55].
Hypofractionation
Standard fractionation is based on one daily treatment five times a week with doses of
1.8Gy to 2.0Gy. For fraction doses above 2.0Gy, the number of fractions has to be
reduced in order to achieve the same BED. This is called hypofractionation. If the α/β
ratio for the tumor is smaller than for late reactions in normal tissue, a higher fraction dose
leads to less repair in the tumor compared to normal tissue. With increased tissue sparing
due to modern treatment techniques like IMRT or VMAT (see section 4.2.3) or with the
introduction of image guided radiation therapy (IGRT) (see section 4.4), hypofractionated
concepts gain attractiveness for more possible treatment sites even with slightly higher
α/β ratios [10, 55].
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4.3 Dose Calculation Algorithms
For both forward and inverse planning different algorithms for dose calculation are avail-
able in commercial TPS. Accurate and fast 3D dose calculations link the chosen treatment
parameters and the clinical outcome of the treatment technique. The calculated distri-
bution of the absorbed dose is the primary physical quantity for analyzing the clinical
effects of the treatment strategy. Speed and sufficient accuracy are the mutually conflict-
ing goals of dose calculation algorithms [10]. Dose calculation algorithms can be divided
into two different groups: kernel based superposition or convolution methods, such as pencil
beam (PB) or collapsed cone (CC), which use a specific model for dose calculation, and
direct approaches, such as Monte Carlo (MC) solvers.
4.3.1 Kernel-Based Superposition/Convolution Methods
Certain approximations or models have to be implemented in order to increase the speed
a of dose calculation algorithm. All model-based algorithms describe the physical process
of energy deposition by the radiation field only to some extent. At first, the treatment
machine has to be modeled, which is typically accomplished using a model for photon
primary energy fluence with the energy spectrum and the measured beam properties of
the LINAC. This model can be used as an input for all calculations of energy absorption
and transport in the patient tissue. The absorption of primary photons is expressed by
the term total energy released per unit mass (TERMA) T (r⃗) released by a radiation field
interacting with a medium (of density ρ) at a certain point r⃗, with µ denoting the linear
photon absorption coefficient [7, 10]:
T (r⃗) =
µ
ρ
(r⃗)Ψ(r⃗) (4.6)
Specific dose kernels model the energy transport via secondary photons and electrons
[10]:
 Pencil Beam (PB) The PB algorithm is the simplest and therefore the fastest
method of dose calculation. The PB kernel is the integration of all point-spread
functions (the energy spread around a single primary unscattered photon interaction)
along an infinite ray of photons [43]. The accuracy of PB algorithms is limited in
inhomogeneous tissue with large density variation such as in the lung [66]. Also,
secondary photon and electron interactions which occur in any other direction than
the incident beam angle are discarded by the PB algorithm, because all matter in
the lateral direction of the beam is assumed to be water.
 Collapsed Cone (CC) A more accurate and sophisticated algorithm, especially for
inhomogeneous media, is the CC algorithm, where single process lateral scattering
and backscattering are accounted for to some extent. Here, angular discretization of
the kernel into cones increases the efficiency of the calculation of energy transport
and deposition [5, 6]. The angular discretized kernel is convolved with the TERMA
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distribution, which leads to an energy deposition into the voxels in the cone direc-
tion of the central cone axis. The accuracy can be increased using a finer angular
discretization.
4.3.2 Monte Carlo (MC) Approach
A direct method without the usage of model approximations is the MC algorithm widely es-
tablished as a statistical method for performing numerical integrations. Before absorption,
photons have a limited number of possible interactions, which can be simulated directly.
MC methods are older than 200 years and can be used to solve mathematical problems,
for example the numerical integration of functions using random numbers. The function
value for a random number multiplied by the length of an integral provides a first and
rough estimate of the real integral. If a large number of random numbers is sampled,
the area of the corresponding rectangles and the mean of the areas is calculated. In the
limit of infinite random number samples, this mean values converges to the real integral.
The importance for this algorithm, which is less efficient than other algorithms for one
dimensional algorithms, becomes imminent in high-dimensional problems like the dose dis-
tribution in a patient caused by ionizing radiation [10]. MC is considered the primary
benchmark method for faster dose calculation algorithms [6] and is also nowadays widely
used in clinical routine because of reduced processing times due to adapted algorithms
for radiation therapy and much faster and more affordable computer processors. The MC
dose calculation algorithm simulates the stochastic processes of primary and secondary
photon and secondary electron interaction until the particle and all secondary particles
are absorbed. Some approximations (e.g. ”condensed history” techniques) simplify the
number of interactions for secondary electrons along the path through the patient using
the assumption, that medium is locally homogenous [6, 10].
Dose-to-water vs. Dose-to-medium
Kernel-based dose calculation methods report the absorbed dose-to-water with different
electron densities, as the machine parameters used as input data for a standard conven-
tional TPS are generally measured in water phantoms. The assumption of the human body
consisting solely of water is obviously not correct, although it is a good approximation.
The conversion between dose-to-medium and dose-to-water can be carried out by applying
Bragg-Gray cavity theory. With the introduction of the MC approach, the energy depo-
sition is directly calculated in the medium and the dose-to-medium is reported directly.
Differences up to 11% can be found when converting doses-to-water from doses-to-media,
depending on the type of medium and especially for voxels containing mixed types such as
air, bone, and soft tissue [38].
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4.4 Image Guided Radiation Therapy
Patient positioning is nowadays accomplished using imaging data acquired at the LINAC,
shortly before or even during treatment, in order to ensure either a well-positioned patient
or the correct position of the PTV (the so-called target centered approach). The process
of patient surveillance using 2D, 3D, or even 4D imaging techniques is called IGRT [27, 68]
and leads to significant reductions in PTV treatment margins and therefore to a reduction
of the dose to nearby OARs [21]. The simplest method is the usage of an electronic portal
imaging device (EPID), where the 2D projection of the LINAC beam is recorded using
digital imaging devices, such as amorphous silicon flat panel detectors and (less frequently
used) liquid ion chambers. The rather bone-based image with low soft tissue contrast due
to the dominant Compton effect (see 3.2.4) in the MV range is compared to a digitally
reconstructed radiograph (DRR), which is a 2D X-ray simulated by the TPS. As in some
cases the patient’s bony structures or the central lung distance (CLD) provide enough in-
formation for positioning, this technique is still in use clinically nowadays.
When the 2D and low contrast EPID imaging is not sufficient, multiple 3D options remain:
The most widely used one is the so-called cone-beam computed tomography (CBCT). The
usage of CBCT in radiation therapy was first described in 2000 as an adaption from its
applications in dentistry [26]. An in-room independent X-ray source and an opposing cor-
responding 2D digital detector panel are mounted to the LINAC. From a set of several
2D projections obtained through rotation of source and detector around the patient, a 3D
reconstruction of the patient’s anatomy can be obtained with higher, but not identical
properties as a fan-beam CT, such as high spatial resolution and better soft tissue con-
trast than megavolt (MV) images, but with less reliable HU values than the planning CT.
The 3D reconstruction can be registered to the patient’s planning CT, allowing for precise
patient positioning according to the daily anatomy.
In addition, the usage of MRI, tracking of implanted fiducial radiopaque markers, tu-
mor tracking with implanted transponders (Calypso®, [70]), stereoscopic in-room X-ray
imaging, or ultrasound tracking devices are already implemented clinically for IGRT in
multiple dimensions and also with regards to time and should be therefore mentioned.
4.4.1 Stereotactic Body Radiation Therapy
Stereotactic Body Radiation Therapy (SBRT) is defined as a method of radiation therapy,
which accurately delivers a high radiation dose in only one or few fractions (hypofraction-
ated, see section 4.2.4) to an extracranial target volume. SBRT can be performed with
a traditional LINAC with IGRT technology, a LINAC specifically adapted for the usage
of SBRT, or also dedicated delivery systems. A systematically optimized SBRT workflow
has to be established and specialized quality assurance (QA) methods have to be devel-
oped for an adequate irradiation delivery. One important procedure in the workflow is the
possibility of accurate tumor localization with site specific imaging modalities. For early
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stage medically inoperable stage I NSCLC, SBRT is shown to perform superior compared
to conventional radiation therapy and is nowadays considered the standard of care for
medically inoperable patients [23]. The dose to the PTV is usually prescribed to the 65%
or 80% isodose line for a steep dose gradient outside of the PTV without the necessity
of homogeneous dose distributions inside the PTV. An example of a dose distribution for
SBRT can be found in figure 4.8(b).
(a) An axial (left), coronal (middle), and sagittal CT slice of a patient treated with
SBRT with the target volumes delineated (red: PTV; purple: ITV, dark red: GTV in
maximum inhale and maximum exhale, yellow: GTV delineated from the 3D planning
CT.
(b) The corresponding dose gradients to the PTV. The dose to the PTV was 40.5 Gy
prescribed to the 65% isodose line (bright green).
Figure 4.8: An exemplary SBRT treatment plan in all three CT imaging planes.
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Chapter 5
Uncertainties in Lung Radiation
Therapy and Advanced Methods for
Uncertainty Mitigation
In lung radiation therapy, various sources of uncertainties exist and have to be accounted
for, especially when treating the patient with only few fractions using the SBRT treat-
ment technique. The first section of the following chapter gives an overview of geometrical
uncertainties in the treatment planning process, and errors and uncertainties, which arise
during treatment within one fraction (intrafractional) or between multiple fractions (inter-
fractional). When treating sites in the upper abdomen or thorax, tumor breathing motion
is one of the major challenges. The second section of the chapter describes different strate-
gies for breathing motion management, including the process of four-dimensional (4D)
treatment planning.
5.1 Geometrical Uncertainties
Geometric uncertainties arise from multiple sources: patient set-up variation, organ mo-
tion and deformation, and machine related errors [25]. Machine-related geometrical errors,
such as isocentric deviations between gantry, collimator, LINAC table and the imaging
system, or deviations in beam shapes and sizes due to MLC uncertainties, are considered
relatively small in comparison to daily set-up variations or organ motion [63]. With ade-
quate QA procedures, the magnitude of machine-related geometrical errors can be reduced
to a minimum. The safety margin from the GTV to the PTV accounts for geometrical
errors. The GTV delineation process itself is also prone to uncertainties, for example the
limited resolution of imaging modalities leading to a partial volume effect, intraobserver
variations, interpretation differences between observers or imaging modalities, or unclear
delineation guidelines [65].
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5.1.1 Intrafractional & Stationary Interfractional Patient Set-Up
Variations
The positioning of the patient and far more importantly the positioning of the PTV in
modern SBRT treatments using IGRT methods were described in section 4.4. IGRT meth-
ods account for interfractional setup errors by using for example daily CBCT corrections
for lung SBRT, careful immobilization, or well-designed setup protocols [65]. These setup
errors have random and systematic components. Intrafractional variations in lung radio-
therapy are target uncertainties, which are due to breathing motion (on a timescale of
seconds) or the variability in the breathing pattern, or a baseline drift in breathing motion
(on a timescale of minutes). Breathing motion will be discussed in the next section. Base-
line drifts or breathing pattern variability can be accounted for using additional margins or
image guidance and direct tumor motion monitoring during the radiotherapy fraction, as
it is already in practice using the CyberKnife® system (Accuray Inc., Sunnyvale, United
States) [4, 45, 50, 61]. A reduction of treatment time also reduces the variability using
techniques like VMAT or the so-called flattening filter free (FFF) technique, where the
flattening filter in the LINAC treatment head is retained from the beam for higher dose
rates.
Interfractional uncertainties include the rigid patient setup accuracy and inter-day base-
line variability with respect to the bony structures on a timescale of days. Daily patient
positioning with target based IGRT can account for most of these potential errors. If the
target-based IGRT is conduced rigorously well in clinical practice, the interfractional com-
ponent of the safety margin can be reduced to almost zero. Anatomical deviations, such
as tumor shrinkage or atelectasis, also bear the risk of increased errors and the treatment
plan should be adapted accordingly.
5.1.2 Respiratory Organ Motion
Respiration-induced organ motion is considered the largest intrafractional organ motion
compared to intrafractional motion caused by the skeletal muscular, cardiac, and gastroin-
testinal systems. Respiratory motion is highly patient-specific and not rhythmic, unlike
cardiac motion. The amount of lung tumor motion during breathing varies widely, mostly
in the superior-inferior (SI) direction with typical amplitudes of∼ 10mm (for some patients
up to over ∼ 30mm) and also with (smaller) possible components anterior-posterior (AP)
and right-left (RL) [40, 60, 62]. An example of possible lung tumor motion is depicted in
figure 5.1. No general patterns nor assumptions on the patient-specific respiratory motion
can be assessed prior to CT acquisition and treatment. Breathing motion has many indi-
vidual characteristics such as quiet versus deep, chest versus abdominal, or healthy versus
compromised [31].
The problems of respiratory organ and tumor motion during radiation therapy arise
during image acquisition, treatment planning, and radiation delivery: motion artefacts
compromise the acquisition of all imaging modalities such as the static CT used for tumor
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Figure 5.1: Orthogonal projections of the trajectories of lung tumors in the coronal (left)
and sagittal (right) plane [60].
delineation and dose calculation. Typical for thoracic 3DCT images is a blurring or arte-
facts in the region of the diaphragm. Using 4DCT datasets, respiratory motion artefacts
are largely reduced but the image quality of the reconstructed 4DCT dataset also has an
influence on the delineated GTV structures in each breathing phase and on dose calcu-
lation on the dataset due to differences in the medium density and therefore also in the
resulting dose. A method of improving 4DCT reconstructions with respect to the quality
of delineation is introduced in chapter 6. During treatment planning, tumor respiratory
motion is accounted for using the ITV delineation approach, as discussed in section 4.2.1.
During the radiation delivery itself, intrafractional respiratory tumor motion can cause
averaging or blurring of the static dose distribution along the path of motion, leading to
anatomical deviations in intended and actually delivered dose distributions [31]. Figure
5.2 shows possible deviations between two respiratory phases for an exemplary patient.
Additional challenges for high-dose lung radiation therapy is the handling of low density
tissue inside the PTV surrounding the higher density tumor to be irradiated: the higher
density tissue absorbs more dose than low density lung tissue or air surrounding the tumor.
The PTV is simply a virtual, non-anatomical planning volume according to the ICRU def-
inition [24, 25]. The low density of lung tissue surrounding the tumor is an issue in the
comparison of planned PTV dose and the actual dose to the tumor.
For modulated treatments such as IMRT and VMAT, the interplay effect is also a possible
source of uncertainties caused by dynamic respiratory motion in addition with moving el-
ements of the LINAC. The LINAC components also ”move” intrafractionally, for example
the leaf movement in DMLC or VMAT techniques for small segments of the treatment
plan, or even the movement of the leafs with a static gantry in step-and-shoot IMRT treat-
ment plans. If the irradiation segment does cover the tumor at that time, because of some
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segments applying dose to only parts of the PTV or the ITV at some timepoints due to
tumor motion out of the irradiation field, less dose is irradiated on the tumor and the
desired planned dose distribution is compromised.
Figure 5.2: Example of possible deviations in tumor position between different respiratory
phases: maximum inhalation (green) and maximum exhalation (purple) breathing phase.
A tumor motion of about 27mm in CC direction has been measured for this patient.
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5.2 Advanced Methods for Uncertainty Mitigation
in the Presence of Respiratory Motion
In radiation therapy, all known possible uncertainties have to be accounted for. The easiest
way for the compensation of respiratory motion would be the increase of the treatment
margin, but this approach would also increase the volume of healthy tissue exposed to
high doses. As more healthy tissue is irradiated, the probability of treatment-related com-
plications increases. An expanded PTV also limits the possibilities of delivering a high
and adequate dose to the target itself [29]. If the treatment margin is not increased,
respiratory motion can be accounted for using different techniques described in the fol-
lowing section: motion-encompassing methods, respiratory gated techniques, breath-hold
techniques, forced shallow-breathing methods, and the respiration-synchronized technique
[31].
5.2.1 Management of Breathing Motion in Radiation Therapy
Motion-Encompassing Methods
For treatment planning, tumor respiratory motion can be encompassed using different CT
imaging techniques to include the full tumor motion range at the time of CT acquisition.
One method is slow CT scanning, where the CT couch is moving very slowly through the
CT gantry with or without an averaging of multiple CT scans during the acquisition time.
This results in a tumor-encompassing volume in high contrast areas with the full extent of
respiratory motion, but leads to motion blurring which could induce large observer errors
in tumor and normal tissue delineation. Also, two gated or breath-hold CT datasets can be
recorded, one at maximum inhalation and another at maximum exhalation. The blurring
effect is reduced significantly, but the exhalation scan tends to underestimate lung volume
and therefore overestimates the percentage of irradiated lung tissue with high doses. As
mentioned in chapter 4.1.2, the acquisition of 4DCT scans is considered the standard for
obtaining high quality CT datasets in the presence of respiratory motion. The multiple
4DCT phases (or also the maximum exhalation and inhalation CT scans) can be used
for the creation of average intensity projection (AIP) (a CT dataset with the average CT
number found in a given voxel in the dataset [19], see figure 5.3(a)) and maximum intensity
projection (MIP) (a CT dataset with the maximum CT number found in a given voxel in
the dataset [64], see figure 5.3(b)) reconstructions. In addition, a mid-ventilation scan [72]
can be derived from a 4DCT scan, with the time-averaged tumor position.
All of the above mentioned techniques help to improve the delineation process of the GTV
in multiple respiratory phases and increase the quality of the target volumes. The treatment
margin is now encompassing the full tumor motion range using the ITV approach. However,
different strategies for PTV margin reduction exist and the previously described methods
do not account for the inter- and intrafractional tumor motion variability. More details on
respiratory motion management in radiation therapy can be found in [31].
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(a) AIP
(b) MIP
Figure 5.3: Example of AIP (a) and MIP (b) dataset derived from a 4DCT dataset (left:
axial; right top: coronal; right bottom: sagittal). The motion range is encompassed in
both methods with the average CT number for AIP reconstructions and the maximum CT
number for MIP reconstructions.
Free-Breathing Respiratory Gated Techniques
One technique for the reduction of the PTV size is the application of dose only during
a specific portion of the patient’s respiratory cycle. This can include multiple breathing
phases and is referred to as gate. The size and therefore the duration of the specific gate
can be determined and monitored using external (or internal) respiratory motion surrogate
signals or implanted radiopaque fiducial markers. Gating can be delivered using either
the displacement of the breathing curve (displacement gating) or the respiratory phase
information (phase gating), similar to amplitude-based and phase-based 4DCT acquisition,
respectively (see section 4.1.2). External respiratory motion surrogates include optical
surface scanning (see section 4.1.3) or optical tracking of infrared markers placed on the
patient surface. Using spirometry, the lung volume can also be used as an ”internal”
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motion surrogate. The limitations of surrogates are obvious: relying on an external motion
surrogate does not necessarily give adequate information on the internal actual tumor
movement due to various factors, such as baseline drifts and the patient-specific breathing
variability [31].
Ideally, either real time tracking of implanted fiducial markers or the tumor itself using
image guidance for a synchronization of the tumor location with a specifically prepared
4D treatment plan would be necessary also for gated delivery, with or without the use of
online predictive respiratory motion monitoring. The dose from the 4D plan intended for
a certain breathing phase could be delivered based on the actual motion state [53]. The
LINAC beam-on and beam-off latency is one of the most crucial factors in implementing
gated treatment methods. In chapter 8, the possibilities and drawbacks of gated delivery
are assessed in terms of latency and dosimetrical aspects, as part of this thesis.
Breath-Hold Techniques
The patient breath-hold reduces the dynamic component of breathing motion. Again,
a respiratory motion surrogate is used to determine the tumor location and the LINAC
is gated to that exact point. The same limitations as for standard gated treatments in
free-breathing apply, but keeping a stable breath-hold condition over a longer period of
irradiation time makes a reduction of potential risks possible. The technique is used in lung
cancer radiotherapy with motion surrogates, such as spirometry, infrared markers placed
on the patient’s surface, or optical surface scanning. The method is nowadays also more
widely used in breast radiotherapy, where the deep breath-hold increases lung volume.
With the caudal movement of the diaphragm, the heart as a crucial OAR is moved out of
the radiation field [58]. The level of inspiration differs in different techniques: reproducible
breath-hold states can be accomplished in DIBH (the maximum possible inspiration), a
pre-defined respiration state, which is not the absolute maximum, or voluntary breath-hold
[31].
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Figure 5.4: An example of the DIBH gating technique for breast patients. Green: patient
surface during free-breathing; blue: patient surface during DIBH. The red spot on the
surface indicates the measured gating spot. On the right side, the patient breathing curve
is displayed in red and the gating window can be seen in green (dashed).
Forced Shallow-Breathing Methods
Another possibility of reducing the PTV margin is forced shallow breathing (FSB) using
abdominal compression. A plate attached to a stereotactic body frame is used to apply
pressure to the patient’s abdomen, reducing diaphragmatic excursions. This technique is
mostly used in the treatment of liver, kidney, pancreatic or early stage lung tumors. Tumor
motion amplitude reductions from 8-20mm (12.3mm mean) to 2-11mm (7.0mm mean)
have been reported using abdominal compression [44]. Figure 5.5 shows an exemplary
sagittal CT slice of a patient treated with abdominal compression.
Respiration-Synchronized Technique
The respiration-synchronized technique, more commonly known as real time tumor track-
ing, is a method where the radiation beam follows the exact tumor path during the whole
treatment fraction. Ideally, respiratory motion margins can be eliminated using this tech-
nique, but several technical difficulties are still present. The position of the tumor has
to be monitored constantly and in real time, the tumor position has to be estimated in a
predictive manner with high precision, the beam has to be dynamically positioned accord-
ingly, and the dosimetry of the changing lung volume has to be accounted for adaptively
[31]. Various algorithms for motion modeling and prediction already exist and are partially
used in distinct radiation therapy systems to compensate for tumor motion [41].
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Figure 5.5: Sagittal CT slice of a lung cancer patient treated with abdominal compression
for the restriction of the tumor motion amplitude.
5.2.2 Four-dimensional Treatment Planning
4D treatment planning uses more than one 3D image dataset for the evaluation of the
dose to moving targets and OAR structures. Either a full 4DCT dataset with typically
8-10 respiratory phases is used for treatment planning, or synthetic datasets generated
from the 4DCT (such as AIP, MIP, or mid-ventilation scans, see section 5.2.1) provide
the information of the patient anatomy and therefore the CT electron density at a certain
timepoint. Including the temporal dimension in the treatment planning process allows to
compensate for the high patient-specific breathing variability. Each dataset is used for
planning, similar to the 3D treatment planning approach, which leads to an optimal plan
for the breathing-induced changes in the anatomy. The individual doses in each sampled
timepoint are subsequently merged to result in a dynamic patient model. This is referred
to as 4D dose accumulation, dose mapping, or dose reconstruction. Deformable image
registration [14] methods provide a non-rigid body voxel congruity between all volumetric
CT datasets and is used for dose mapping. The dose distribution on each secondary dataset
is accumulated and scored back on a reference dataset for evaluation. The whole workflow
of dose accumulation to a single dataset is potentially prone to multiple error sources, such
as artifacts in the 4DCT datasets, errors in the deformable registration process which could
induce errors in dose mapping, or certain limitations of the dose mapping algorithms in
regions with strong density variation. Different methodologies for 4D treatment planning
can be found in Rosu et al. [53]. As part of this thesis, an approach for 4D Monte Carlo
dose calculation on different image dataset has been implemented in chapter 7.
50 Uncertainties in Lung Radiation Therapy and Advanced Methods for Uncertainty
Mitigation
Chapter 6
Paper 1: Comparison of Different
Image Binning Algorithms for 4DCT
Reconstruction for Radiation
Therapy
Publication: Comparison of different image binning algorithms for 4DCT recon-
struction for radiation therapy 1
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Abstract
Respiratory motion remains a source of major uncertainties in radiotherapy. Respiratory correlated computed tomography
(referred to as 4DCT) serves as one way of reducing breathing artifacts in 3D-CTs and allows the investigation of tumor
motion over time. The quality of the 4DCT images depends on the data acquisition scheme, which in turn is dependent on the
vendor. Specifically, the only way Toshiba Aquilion LB CT scanners can reconstruct 4DCTs is a cycle-based reconstruction
using triggers provided by an external surrogate signal. The accuracy is strongly dependent on the method of trigger
generation. Two consecutive triggers are used to define a breathing cycle which is divided into respiratory phases of
equal duration. The goal of this study is to identify if there are advantages in the usage of local-amplitude based sorting
(LAS) of the respiration motion states, in order to reduce image artifacts and improve 4DCT quality. Furthermore, this
study addresses the generation and optimization of a clinical workflow using as surrogate motion monitoring system the
SentinelTM (C-RAD AB, Sweden) optical surface scanner in combination with a Toshiba Aquilion LB CT scanner. For
that purpose, a phantom study using 10 different breathing waveforms and a retrospective patient study using the 4DCT
reconstructions of 10 different patients has been conducted. The error in tumor volume has been reduced from 2.9 ± 3.7%
to 2.7 ± 2.6% using optimal cycle-based triggers (manipulated CBS) and to 2.7 ± 2.2% using LAS in the phantom study.
Moreover, it was possible to decrease the tumor volume variability from 5.0 ± 3.6% using the original cycle-based triggers
(original CBS) to 3.5 ± 2.5% using the optimal triggers and to 3.7 ± 2.7% using LAS in the patient data analysis. We
therefore propose the usage of the manipulated CBS, also with regard to an accurate and safe clinical workflow.
Keywords: 4DCT, Local amplitude-based sorting, Radiotherapy, Optical laser surface scanner, Respiratory motion mon-
itoring
1 Introduction
In radiation therapy considerable uncertainties in treatment
planning of thoracic and upper abdominal sites still remain
due to respiratory motion [1]. An increase in treatment
margins does account for these motions, but increases
∗ Corresponding author: P. Freislederer, Department of Radiation Oncology, University Hospital, LMU Munich, D-81377 Munich, Germany.
E-mail: philipp.freislederer@med.uni-muenchen.de (P. Freislederer).
the dose to normal tissue [2]. Besides challenging correct
treatment delivery, motion of anatomical structures also often
deteriorates the image quality of computed tomography (CT)
in these treatment regions [3], which later on are being used
for treatment planning. Four-dimensional computed tomog-
raphy (4DCT), also referred to as respiratory-correlated
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computed tomography (RCCT), can be used to reduce
breathing induced motion artifacts which can occur in a
“static” CT and allows the detailed investigation of tumor
movement with regards to time [4,3,5–7]. Concerning the
time-resolution, a certain type of surrogate signal is always
needed to sort the acquired oversampled CT raw dataset
into multiple datasets, so-called 4DCT phases. Respiratory
monitoring systems are required to provide accurate surrogate
breathing signals in order to acquire any 4DCT. For Toshiba
Aquilion CT scanners, these signals need to be provided
as cycle based online trigger pulses, each indicating a
new breathing cycle. A major problem in providing these
prospective trigger pulses is that one has to be certain that
each trigger represents the same breathing phase, for example
the so-called 0% phase at maximum inhalation. Also, if the
CT reconstruction algorithm equally divides the phases in
between two trigger pulses, errors in reconstruction cannot
be neglected as respiratory motion suffers from irregularities
[2,8].
The goal of this study was to generate and optimize a clin-
ical workflow using the SentinelTM (C-RAD AB, Stockholm,
Sweden) optical surface scanner as a surrogate motion mon-
itoring system in combination with a Toshiba Aquilion CT
scanner. Also, we investigated the variations of image quality
in two different image sorting algorithms: Cycle-based sor-
ting (CBS) and local amplitude-based sorting (LAS) based on
a phantom study using 10 different breathing waveforms and
a patient study using the 4DCT reconstructions of 10 different
subjects.
2 Methods and materials
For the phantom evaluation, 4DCT datasets of a Dynamic
Thorax Phantom (CIRS Inc., Norfolk, VA, USA), each with
a different breathing curve, were acquired using a Toshiba
Aquilion 16 Large Bore CT scanner with the AquilionLB
Software Ver3.38ER005 (Toshiba Medical Systems Corpora-
tion, Otawara, Japan). The motion signal was recorded using
the SentinelTM optical laser-based surface scanner [9]. As the
SentinelTM is recording the breathing signal via laser on a
certain, user-defined spot on the patient’s surface, the phan-
tom had to be extended using thermoplastic mask material to
simulate a patient’s upper body visible to the scanner. This
thermoplastic mask is attached to the surrogate motion motor
of the CIRS phantom and is used to simulate a breathing
motion of a phantom thorax. All 4DCTs for the phantom mea-
surements were acquired and reconstructed with following
parameters: slice collimation of 16 × 1.0 mm, helical pitch of
1.2, rotation time of 0.5 s, matrix of 512 × 512, tube voltage
of 120 kV and tube current of 150 mA. Images were finally
reconstructed in 1 mm slices and a pixel size of 1.074 mm. For
the phantom study, an acrylonitrile butadiene styrene (ABS)
copolymer sculpture (LEGO
®
, Billund, Denmark) served as a
“tumor” in the lung phantom. This special structure has been
Table 1
Overview of the breathing motion characteristics for the patient data
evaluation. Tumor motion has been measured using an in-house
developed software tool and is not evaluated specifically here. In
patients 4 and 7, two different tumor sites have been investigated.
Mean
respiratory
rate/bpm
Surrogate
motion
range/mm
Baseline
drift/%
Tumor movement/mm
CC AP RL
Pat 1 11.9 17.8 5.0 15 5 1
Pat 2 13.0 3.3 3.3 6 3 2
Pat 3 17.8 9.3 1.3 9 3 3
Pat 4(1) 16.4 8.3 0.4 6 3 3
Pat 4(2) ” ” ” 5 5 3
Pat 5 19.4 9.2 0.1 9 2 1
Pat 6 15.3 9.3 33.7 3 2 2
Pat 7(1) 11.1 19.9 1.6 3 1 1
Pat 7(2) ” ” ” 12 4 1
Pat 8 12.8 5.3 10.9 6 6 3
Pat 9 11.0 6.8 −1.7 6 3 2
Pat 10 19.0 8.8 1.5 15 3 1
used because of its distinct edges and multiple spikes and
corners. If the CT image quality is to be determined, these
structures serve as a valid measure if they are visible in the
reconstruction.
For the patient data evaluation, the 4DCTs of 10 consec-
utive patients (3 males, 7 females, age between 34 and 84
years (mean age 70.5 years)) treated in clinical routine for
pulmonary metastases (n = 6) and non-small cell lung cancer
(NSCLC) (n = 4) were selected for the retrospective analysis.
All patients were treated with hypo-fractionated stereotactic
body radiotherapy (SBRT) and therefore received 4DCTs as it
is standard clinical practice at our institution. Patient breath-
ing waveform characteristics can be found in Table 1. Baseline
drift has been calculated according to [3] and is depicted as a
percentage of the normalized mean amplitude for each patient.
All 4DCTs were reconstructed in 3 mm slices due to the clin-
ical protocol. The respiratory monitoring evaluation point of
the laser surface scanner has always been placed in the region
of the diaphragm of the patient on the patient’s right side.
This point on the patient’s surface has been chosen accord-
ing to [10] as it is expected to provide the least interferences
with cardiac movement, less phase shift than a spot lower in
the abdomen of the patient, and a better signal-to noise ration
(SNR) than any other point on the patient’s thorax due to a
higher amplitude.
All patients gave written informed consent to data collection
prior to treatment. The study was in accordance with the dec-
laration of Helsinki (latest version) and has been approved by
the independent ethics committee of the University of Munich
(573-15, issued on October 10th, 2015).
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2.1 Data acquisition and 4DCT data sorting
RCCTs were acquired in helical mode while the breath-
ing waveform was recorded by the SentinelTM scanner. This
surface scanner uses a threshold method to try to determine
the maximum of the breathing curve which is then sent to the
CT as a trigger pulse. The position of this threshold is crucial
for the CT scan quality: To obtain trigger pulses at the maxi-
mum inhale phase (and therefore always at the same distinct
phase during the course of the CT) the threshold has to be
set as high as possible with regards to the breathing wave-
form. Due to baseline drifts, breathing irregularities, and even
bending of the CT couch during the acquisition time of the
CT scan [10], there will be a risk of missing triggers when set-
ting the threshold too high. Here, the threshold has been set to
about 80% of the breathing curve maximum by monitoring the
breathing waveform prior to the 4DCT for a certain amount
of time. This results in an early triggering of the CT scan
before maximum inhalation, but minimizes the risk of miss-
ing triggers. It is important to note that the 80% threshold level
can only be chosen before the start of the actual CT acquisi-
tion. Therefore, the optimal threshold level would have to vary
in relation to the breathing curve throughout CT acquisition.
The CT uses these triggers to assign ten equidistant breath-
ing phases to the oversampled raw data acquired during the
acquisition time of the CT scan. This reconstruction method
is what we later refer to as “original” cycle-based sorting
(Original CBS).
One major source of error in the assignment of the triggers
hereby is the prospective threshold method of the SentinelTM
system: Baseline drifts and variations of the breathing curve,
which can occur with every real patient, will not allow this
method to generate trigger pulses at the maximum of the curve
while securing that no trigger pulse is left out in the acqui-
sition. To overcome these restrictions, an in-house software
solution was built using MATLAB
®
(The MathWorks Inc.,
Natick, MA, USA), in which the real maxima of the previously
stored breathing signal during 4DCT acquisition are deter-
mined using the zero crossing of the first derivative of the input
signal. Retrospective user interaction is needed to control and
eventually adjust the calculated maxima which are eventu-
ally used as new trigger pulses for the CT reconstruction.
Using these new trigger pulses, the CT can reconstruct the ten
4DCT phases in equidistant timepoints between two maxima
of the breathing waveform. This method is later on referred
to as “manipulated” cycle-based sorting (Manipulated
CBS),
Additionally, a local amplitude-based sorting (LAS) algo-
rithm has been implemented: The real maxima and the minima
of the previously acquired breathing curve are determined
offline, again according to the zero crossing of the first deriva-
tive. Subsequently, the actual phase of each breathing cycle is
determined by dividing the amplitude between the decrease
from maximum to minimum into 5 equidistant steps and
repeating the same procedure for the increase to the next max-
imum. This way, it can be ensured that the 0% phase of the
4DCT is always at the maximum of the breathing curve while
the 50% phase is always at each minimum. A comparison of
these three different techniques (original CBS, manipulated
CBS, and LAS) is depicted in Fig. 1.
Figure 1. Comparison of the three different image sorting algorithms. One full breathing cycle for each binning method is indicated with
the highlighted background of the trigger pulses. The original CBS approach (orange) uses a threshold in order to determine the 0% phase
of the breathing waveform and thus generates trigger pulses always ahead of the real maximum. Through correction (manipulated CBS,
magenta) this phase shift is eliminated. The influence of LAS (green) becomes obvious at the presence of breathing irregularities.
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2.2 Data evaluation
The performance of the three different binning methods
(original CBS, manipulated CBS, and LAS) have now been
compared by evaluating each “tumor” volume of the corre-
sponding reconstructed 4DCT motion phase. For the phantom
study, a MATLAB
®
script was implemented for an intensity-
based automatic segmentation of the “tumor” and volume
differences could be evaluated and compared to the “tumor”
volume observed in a CT scan in absence of any tumor
motion, which is referred to as reference CT. The means
and standard deviation values for the volume differences
between the individual 4DCT phases and the reference CT
have been calculated over all breathing curves used on the
phantom.
For the patient study, the tumor has been delineated in each
single breathing phase using Oncentra Ver4.3.0.410 (Nucle-
tron B.V., Netherlands) by an experienced radiation oncologist
and controlled by a supervising radiation oncologist. As usu-
ally no reference CT without tumor movement is available in
real patient data, tumor volume variability (TVV) has been
calculated as the relative difference between the tumor vol-
ume in each respiratory phase to the mean tumor volume over
all 4DCT phases for each reconstruction method. Addition-
ally, the volume of a 3D-CT has been compared to the average
of the ten delineated 4DCT phases in each single respiratory
phase.
A Wilcoxon signed-ranked test has been performed to com-
pare the TVV results of the different reconstruction methods
and Spearman’s rank correlation has been used to determine
to what extend the baseline drift influences the reconstruction.
For statistical significance, p > 0.05 has been chosen.
3 Results
3.1 Phantom evaluation
The mean volume of the “tumor” of the moving phantom
for all breathing curves can be found in Table 2. The original
volume is calculated from the CT dataset of the static tumor as
4.1 cm3 and serves as a reference. The mean and standard devi-
ation values for each phase binning method and each phantom
breathing curve were calculated with respect to the original
volume. The tumor volume in a “free-breathing” 3D-CT scan
with tumor motion has also been calculated for each phantom
motion curve. Due to missing slices in the reconstructions
of the 4DCT phases using patient curves 5 & 6 when using
the original triggers, the resulting volumes cannot clearly be
compared to the other binning algorithms. When rejecting
these volumes from the calculations, the mean difference to
the actual volume (measured using the reference CT) is the
smallest for LAS (2.7 ± 2.2%) and 2.7 ± 2.6% using manip-
ulated CBS. When using the original triggers provided by the
SentinelTM system, the difference is found to be as high as
Table 2
The difference in reconstruction volume to the volume measured in
the reference CT (V). For each 4DCT reconstruction, 10 breath-
ing phases were used per breathing curve. The percentage values
(mean ± standard deviation over all phantom breathing curves) are
always compared to the reference volume of the tumor phantom of
4.1 cm3. As missing slices appear in the reconstructions that used
patient breathing curves 5 and 6, a second calculation has been
performed to exclude the impact of the artifacts.
Pat 5 & 6 included Without patients 5 & 6
V/cm3 V/% V/cm3 V/%
Free breathing CT 0.5 ± 0.7 9.7 ± 16.5 0.5 ± 0.7 13.0 ± 18.0
Original CBS 0.3 ± 0.2 7.1 ± 5.0 0.1 ± 0.2 2.9 ± 3.7
Manipulated CBS 0.2 ± 0.1 4.7 ± 2.8 0.1 ± 0.1 2.7 ± 2.6
LAS 0.2 ± 0.1 4.5 ± 2.4 0.1 ± 0.1 2.7 ± 2.2
2.9 ± 3.7%. The missing slices when using patient curve 6
were due to missed triggers (below the threshold) in the origi-
nal CBS reconstruction, while missing slices in patient curve 5
occurred within all data sorting methods due to the variations
in the breathing rate and the limitations of the Toshiba CT
scanner (raw data acquisition is only possible with breathing
rates ≥10 bpm, see [10]).
On average, LAS provides the least inaccuracies compared
to the volume of the reference CT. With a smaller standard
deviation, the consistency of the LAS method remains more
precise, closely followed by the manipulated cycle-based trig-
ger sorting method. The original trigger sorting scores the
lowest of the three methods. An overview of the individual
relative deviation to the reference volume of the static CT is
depicted in Fig. 2. However, when comparing the results to
the measured volumes in a 3D-CT without any 4D informa-
tion, it turns evident that all 4DCT reconstruction algorithms
investigated will generate a better reconstruction of moving
volumes. The free breathing CT has a mean difference to the
actual volume of 13.0 ± 18.0% when all breathing curves are
taken into account.
3.2 Patient data evaluation
Overall, most patients show reduced TVV when using
both the manipulated CBS and the LAS approach. Con-
versely, TVVs of patient 4 showed no clinically significant
differences when comparing the three different 4DCT recons-
tructions. The relative deviation resulting from manual
contouring is high due to the small tumor volumes of
VTumor M ean = 0.79 cm3. The second tumor site in patient 7
(7/2) was rather hard to delineate due to the surrounding tissue.
As the baseline drift of patient 6 has been estimated to exceed
33%, the superiority of the two new approaches is indicated
by a significantly reduced TVV. Over all patients, exclud-
ing patient 4 due to the significantly small tumor volume and
patient 8 due to artifacts in the 4DCT reconstruction, TVV
has been measured highest when using the “original” proposed
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Figure 2. Comparison of the different data sorting methods for the
phantom study with 10 different breathing curves as an input for the
thorax phantom. The respective relative deviation to the reference
volume with the corresponding standard deviation is depicted here.
The patient curves 5 and 6 were left out on purpose due to missing
slices in the reconstruction.
workflow of the manufacturers relying on cycle-based triggers
(TVVmean = 5.0 ± 3.6%). A significant reduction (p < 0.01) of
TVV is observable by using either the manipulated cycle-
based method or the LAS approach. No statistical significance
between the three methods has been observed when including
all patient datasets except patient 8 (excluded for artifacts).
TVV in the manipulated cycle-based reconstruction could be
reduced from 5.0 ± 3.6% (original CBS) to 3.5 ± 2.5% and
to 3.7 ± 2.7% when reconstructing the 4DCT phases accord-
ing to the LAS approach. Fig. 3 gives an overview of the
Figure 3. Tumor volume variability (TVV) for all patients, as it has
been delineated by an experienced radiation oncologist for the patient
study. TVV was calculated as the relative difference to the mean
tumor volume over all phases. Patient 8 is left out in the graphic due
to artifacts in the 4DCT reconstruction.
patient results excluding patient 8 due to missing slices in the
reconstruction in the tumor volume.
When comparing the tumor volume in the free breathing
CT scan to the average of delineated volumes in each sin-
gle respiratory phase using LAS reconstruction, the need of
4DCTs becomes obvious: Tumor volume was overestimated
in 2 of the 3D-CT scans by 11.0% and 17.0% and underes-
timated in 8 tumor sites ranging from 4.4% to 30.4%. The
correlation between the baseline drift and the difference in
TVV between LAS and original CBS shows that there is a
high positive correlation (r = 0.85), which indicated that the
Figure 4. Example of the different 4DCT trigger binning methods for the moving tumor of patient 5. The red arrows indicate an observable
phase shift (1), artifacts in the reconstruction (2), and missed information in a specific breathing phase (3), all of them appearing in the
original CBS 4DCT reconstruction.
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higher the baseline drift, the better the reconstruction using
the LAS algorithm. The correlation between baseline drift
and the difference between the manipulated and the origi-
nal CBS approach indicates the same with a slightly lower
correlation coefficient (r = 0.70). Fig. 4 demonstrates the vari-
ability of tumor motion in the different respiratory phases
when using different 4D data sorting methods: The phase shift
in the reconstruction using the original cycle-based approach
can be clearly seen in this illustrative case, although all three
reconstructions have their origin in the same raw dataset. This
phase shift adds up to the reconstruction error made by the
original CBS approach.
4 Discussion
We evaluated the imaging workflow using the SentinelTM
laser surface scanner and a large bore CT scanner (Toshiba
Aquilion LB) specifically acquired for exclusive use in a
radiotherapy department, which has to be optimized in order
to be clinically applicable: Using the triggers originally pro-
vided by the SentinelTM system leads to differences in tumor
volume of up to V = 2.9 ± 3.7% even when not taking
missing slices in the different 4DCT phases into account
(V = 7.1 ± 5.0% when accounting for the missed triggers).
Both tested improvements of the workflow showed reduced
tumor volume differences (VManipulated CBS = 2.7 ± 2.6%
and VLAS = 2.7 ± 2.2%).
In the patient data evaluation, TVV was also reduced using
the manipulated CBS and LAS data sorting methods for spe-
cific patient cases, while some 4DCT reconstructions did not
show improvements when using the newly adapted workflow.
As illustrated in Fig. 3, the secondary tumor site in patient 4
and 7 show even larger TVVs when using the manipulated
CBS and the LAS method, while in patient 2 and the pri-
mary tumor site of patient 7, no significant difference in TVV
is observed. These cases seem to restrict the robustness of
the newly proposed workflows, which was demonstrated in
the phantom study. These findings can be attributed to either
small motion amplitudes (patient 7(1)), where a measurement
such as TVV is limited by the minor differences in the various
4DCT phases, or to very small tumor volume, as in patient 4,
where the small absolute volume differences seem to be quite
large relative to the small tumor volume itself. The results also
illustrate the advantages of 4DCT scans compared to a free
breathing CT, which is in good agreement to previous findings
[2]. Tumor volume deviations of up to 13.0 ± 18.0% can lead
to larger uncertainties in planning and evaluation of the tumor
position.
Although the importance of using phase-based algorithms
for image sorting is reported [11,3,12], better image quality
and less motion artifacts are described when using amplitude-
based approaches [13,14]. Werner et al. also describes an
optimized LAS binning approach similar to the one depicted
in this work, in order to minimize artifacts in 4DCT recon-
struction [15]. Other CT vendors offer the possibility of using
different binning algorithms directly, while the simple usage
of these algorithms are limited when using Toshiba CT scan-
ners: Here there is no known functionality of changing the
reconstruction method in the CT console directly. Unfortu-
nately, due to limitations in accessibility to other systems, we
could not perform a thorough comparison of the different CT
scanners and surrogate motion detection systems under com-
parable conditions. Rather, we aimed at closely investigating
the performance of the Toshiba scanner to which we have
access, and propose a clinically viable solution to overcome
limitations of this system, which was obviously not initially
designed for 4D imaging applications in radiation therapy.
With the known abnormalities and irregularities of
breathing signals, there is no other possibility than using ret-
rospective image sorting, especially for lung cancer patients.
Recently, another similar method for the reconstruction of
lossy raw data or irregular breathing motions in 4DCT has
been introduced and tested on a phantom [16]. A reduced
deviation in the measured tumor volume of about 13.4% has
been found when using an alternative LAS algorithm com-
pared to a cycle-based approach. Kupper et al. also concluded
that a need for retrospective adaption of the breathing signal
becomes inevitable at the occurrence of breathing irregular-
ities [16]. Rietzel et al. found improved 4DCT quality due
to reduced residual motion artifacts when using manual ret-
rospective manipulation of the trigger signals sent to a CT
scanner when using a RPM-system (Varian Medical Sys-
tems Inc., USA) [17]. They concluded in congruence with
our results that the RPM system (as well as the SentinelTM
in our case) has originally been developed as a surrogate for
gated treatment and retrospective postprocessing of the trigger
motion trace is needed. The influence of baseline drifts could
not be thoroughly examined in this study, as only two of the
patients evaluated showed drifts of more than 10%, while one
patient with a large baseline drift has been excluded from the
results of the study due to missing slices in the reconstructed
4DCT phases and is only mentioned for completeness.
Missing CT slices are often a consequence of suboptimal
triggering conditions, which apply using the original CBS
method. The breathing signal typically does vary in amplitude
and respiration period. When only using a single threshold in
order to try to determine the maximum inhalation phase, a
high risk of failure occurs: Prospectively trying to choose the
threshold too high will lead to missing triggers while choos-
ing it on a lower threshold level will not trigger the CT in
the desired breathing curve maximum. If the breathing wave-
form remains always constant over time, this low threshold
level would have little impact on the triggering. However, the
possibility of accidentally binning slices from one respiration
phase to a different one remains. When reconstructing 4DCTs
using the original CBS approach, an underestimation of the
absolute tumor movement could occur, as slices in the maxi-
mum inhalation and exhalation phase could be left out in the
reconstruction simply because of the absence of any trigger
at the timepoint.
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Recently, Thengumpallili et al. evaluated the commer-
cially available amplitude and phase-based reconstruction
algorithms in a Toshiba LB CT scanner and did not find
any significant differences in the reconstruction quality, but
pointed out the importance of adaptive retrospective sorting
when variations in the breathing pattern become obvious dur-
ing the CT scan [18]. In the phantom evaluation, factors as
baseline drifts and variability of the breathing signal were sim-
plified in comparison to real patient movements. The baseline
drift has two major sources: one is the previously mentioned
breathing variability as it occurs with every patient, the sec-
ond one has its origin in the position and weight dependent
couch deflection, which is a specific issue of the SentinelTM
laser surface scanner [10]. A compensation of the baseline
drifts as proposed in Guckenberger et al. [3] cannot fully be
implemented at our site and others using a SentinelTM surface
scanner, because a part of the baseline drift is coming from
the couch deflection itself and is not part of an actual drift in
the breathing curve on the patients’ surfaces [10]. It has to
be mentioned, that for the thorax phantom the external sur-
rogate correlated perfectly with the internal movement. This
approximation is no longer valid in realistic patient breathing
motion.
The differences in TVV seem to be of minor clinical rele-
vance when using ITV (internal target volume) concepts, as
these have only limited impact on the final PTV margin. The
real clinical issues are potential phase shifts as they can be
observed here, the possibility of missed slices, the error made
when it comes to 4D calculations, or treatment planning on a
specific breathing phase, including techniques such as gating
or tumor tracking. Even small uncertainties in tumor volume
will lead to errors in dose calculation while phase shifts and
missed slices could lead to significant underestimations of
tumor volume and movement range.
An overall improvement of 4DCT quality by accounting for
breathing irregularities could be visual and/or audio coaching
of the patients [19,20], which also can be an advantage dur-
ing the course of treatment when using ITV concepts and is
essential for more complex methods like gating or tracking.
Patient coaching can only be assured with a clinical setting
that is able to coach the patient during the CT while ensur-
ing that during treatment, the patient receives the exact same
feedback to provide a workflow for efficient and reproducible
biofeedback. 4DCT phases could also be used for the planning
of gated treatment: Improved binning methods can diminish
the error in phase shift in order to gain maximum precision.
But the crucial aspect again is accuracy, as for some linacs, the
delivery latency can be up to 800 ms [21]. If now the phase shift
between the reconstructed CT phase at for example 50% and
the breathing signal at the patient’s surface could be enlarged
due to poor 4DCT reconstruction when using an external sur-
face position as surrogate, errors in gated treatment would
become unforeseeable when one has to account not only for
this phase shift, but also for the linac latency. The outline and
therefore the limit of this study was to focus on geometric
uncertainties in 4DCT reconstruction. When it comes to dis-
tinguishing certain advantages for treatment techniques such
as gating, more measurements have to be performed (i.e. an
examination of the phase shift between surrogate and tumor
motion).
One major problem with the proposed workflow for the
generation of trigger pulses for LAS is the lack in automa-
tion: Toshiba Aquilion CT scanners only allow cycle-based
approaches, so when it comes to unequal phase distances,
one has to manually send trigger pulses at each phase indi-
vidually to the CT scanner and the resulting reconstruction
always has the DICOM tag “RPM 0%” (which represents the
0% phase). So after the reconstructions, one has to be sure
that renaming the breathing phases is performed in a repro-
ducible way. Both of the manipulated workflows (manipulated
CBS and LAS) require user interventions in a deeper level of
the CT IT infrastructure. The resulting 4DCT reconstructions
therefore would have to be validated and tested extensively
because of this manual interference with the certified work-
flow designed by the manufacturers. These user interactions,
if not carried out properly and without any validation process
can lead to significant errors in the assessment of breathing
motions and bears the possibility of underestimating the tumor
movement. Manual sorting therefore has to be carried out with
respect to the complexity and clinical relevance of possible
results.
5 Conclusion
This study showed that 4DCT reconstruction using LAS
and the manipulated CBS approach both reduce TVV when
comparing them to the original CBS approach of the manu-
facturer for all phantom cases and most of the patient cases.
Also, phase accuracy, meaning that the 0% phase will always
represent the maximum inhalation phase, can be assured when
using both improved methods. Due a shift of the triggers in
the original approach, the maximal tumor movement could
be underestimated as some CT slices will be assigned to
different phases because of the static threshold in combi-
nation with breathing variations. It is expected for the LAS
approach to show significant reductions of the TVV when
using more patient data, which is planned in the future,
but the LAS method appears to be quite impractical due
to Toshiba restrictions, as every trigger file for each phase
has to be manually sent to the CT for a single reconstruc-
tion of this motion state. This method would be prone to
errors and could lack in consistency when using it clinically
if it is not implemented by the manufacturers Toshiba and
C-RAD AB.
Therefore, we recommend reconstructing 4DCTs based on
equally divided respiration phases over time with the trig-
ger points set to the true maximum of the breathing curve
(manipulated CBS), which serves as a valid compromise with
minimal extra workload clinically and improved 4DCT image
quality, which should be integrated by the manufacturers. The
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study will continue with the evaluation of more patient data
to validate the clinical concept.
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Purpose: The need for four-dimensional (4D) treatment planning becomes indispensable when it
comes to radiation therapy for moving tumors in the thoracic and abdominal regions. The primary
purpose of this study is to combine the actual breathing trace during each individual treatment frac-
tion with the Linac’s log file information and Monte Carlo 4D dose calculations. We investigated this
workflow on multiple computed tomography (CT) datasets in a clinical environment for stereotactic
body radiation therapy (SBRT) treatment planning.
Methods: We have developed a workflow, which allows us to recalculate absorbed dose to a 4DCT data-
set using Monte Carlo calculation methods and accumulate all 4D doses in order to compare them to the
planned dose using the Linac’s log file, a 4DCT dataset, and the patient’s actual breathing curve for each
individual fraction. For five lung patients, three-dimensional-conformal radiation therapy (3D-CRT) and
volumetric modulated arc treatment (VMAT) treatment plans were generated on four different CT image
datasets: a native free-breathing 3DCT, an average intensity projection (AIP) and a maximum intensity
projection (MIP) CT both obtained from a 4DCT, and a 3DCTwith density overrides based on the 3DCT
(DO). The Monte Carlo 4D dose has been calculated on each 4DCT phase using the Linac’s log file and
the patient’s breathing trace as a surrogate for tumor motion and dose was accumulated to the gross tumor
volume (GTV) at the 50% breathing phase (end of exhale) using deformable image registration.
Results: DD98% and DD2% between 4D dose and planned dose differed largely for 3DCT-based plan-
ning and also for DO in three patients. Least dose differences between planned and recalculated dose
have been found for AIP and MIP treatment planning which both tend to be superior to DO, but the
results indicate a dependency on the breathing variability, tumor motion, and size. An interplay effect
has not been observed in the small patient cohort.
Conclusions: We have developed a workflow which, to our best knowledge, is the first incorporation
of the patient breathing trace over the course of all individual treatment fractions with the Linac’s log
file information and 4D Monte Carlo recalculations of the actual treated dose. Due to the small
patient cohort, no clear recommendation on which CT can be used for SBRT treatment planning can
be given, but the developed workflow, after adaption for clinical use, could be used to enhance a pri-
ori 4D Monte Carlo treatment planning in the future and help with the decision on which CT dataset
treatment planning should be carried out. © 2019 American Association of Physicists in Medicine
[https://doi.org/10.1002/mp.13579]
3268 Med. Phys. 46 (7), July 2019 0094-2405/2019/46(7)/3268/10 © 2019 American Association of Physicists in Medicine 3268
62 Chapter 7
Key words: 4D dose calculation, 4D treatment planning, Monte Carlo, respiratory motion
1. INTRODUCTION
In radiation therapy of thoracic and abdominal tumor sites,
the management of respiratory motion is still one of the great
challenges even in the presence of various motion compensa-
tion approaches, especially in stereotactic body radiation ther-
apy (SBRT).1,2 With increased complexity of treatment
techniques such as intensity-modulated radiation therapy
(IMRT) or volumetric modulated arc treatment (VMAT), the
interplay effect between a dynamically moving multileaf col-
limator (MLC) or the Linac gantry for VMAT and the
intrafractionally moving tumor may become relevant.3–5 The
dosimetric impact is highly dependent on target motion and
the number of fractions6 and can cause differences between
planned and actually delivered dose distributions in the whole
target region and surrounding organs-at-risk (OAR) struc-
tures.7 Using four-dimensional computed tomography
(4DCT), target motion can be evaluated thoroughly.8–11 The
respiratory motion information gained from 4DCT imaging
can be used in various ways: Tumor motion can be encom-
passed in a so-called internal target volume (ITV) structure,12
defined by either the sum of GTVs of a 4DCT or with an
average intensity projection (AIP) or a maximum intensity
projection (MIP),13 which both can be generated from the
4DCT dataset for motion information on a single CT dataset.
Typically, one free-breathing (FB) 3DCT dataset is used for
dose calculations with the restriction of suffering from arti-
facts due to breathing-induced motion of the target and OAR
structures, partially due to limited availability of 4DCTs. MIP
could be used for treatment planning, but may over- or under-
estimate the target volume, while AIP could serve as a valid
CT basis for dose calculations.14–17 Another approach to solv-
ing the problem of modeling dose to a target volume with
high density tissue surrounded by low density lung tissue in
SBRT treatments are density overrides in the planning target
volume (PTV) and the ITV. These overrides also promise to
perform well in comparison with FB and AIP-based dose cal-
culations.18
Monte Carlo dose distributions can be recalculated on
each single 4DCT breathing phase and merged back onto a
3DCT for evaluation.19,20 This so-called 4D dose mapping
has been performed using direct dose mapping,21 energy
transfer methods22, and voxel warping methods.23,24 Simpli-
fied approaches for 4D treatment planning have already been
studied thoroughly. Rosu et al25 concluded that dose differ-
ences between the calculation on multiple 4DCT phases and
a calculation based on a single CT dataset which incorporates
the full breathing motion range (i.e., AIP) is lower than 2%
on three evaluated patients. An overview of 4D treatment
planning options can be found in Rosu et al.26
Linear accelerator (Linac) log files (where each delivered
monitor unit (MU) and the corresponding MLC, gantry, and
collimator positions are recorded) allow a retrospective
creation of the delivered treatment plan. These log files, in
combination with Monte Carlo dose engines and the 4D tar-
get motion information, have been used to build a delivery
reconstruction simulator, in order to evaluate the interplay
effects in a moving phantom.27 However, Monte Carlo calcu-
lations utilizing the actual patient breathing curve over the
course of multiple fractions have not been performed yet.
In this study, first, we aim to combine the actual breathing
trace of a patient cohort with the Linac’s log file and Monte
Carlo 4D dose recalculations for 3D-conformal radiation ther-
apy (3D-CRT) and VMAT treatment plans individually for
each treatment fraction. To the best of our knowledge, this is
the first incorporation of the actual patient breathing trace for
all individual treatment fractions with the Linac’s log file
information and 4D Monte Carlo recalculations of the actual
treated dose. Second, we investigate this workflow by com-
paring the Monte Carlo dose calculation based on a static FB
3DCT, the AIP, the MIP, and density overrides in ITV and
PTV with 4D Monte Carlo dose recalculations, in order to
precisely evaluate which calculation basis can give us the
most reliable results.
2. MATERIALS AND METHODS
2.A. Patients
Five patients (one female and four male, age between 49
and 79 yr, mean age 66.8 yr) treated with SBRT for lung
tumors have been selected for the present study. The main
selection criteria were high tumor mobility resulting in the
evaluation of one lesion in the upper lung lobe and four
lesions in the lower lobe, located close to the diaphragm.
Tumor movement was evaluated using a 4DCT acquired with
a Toshiba Aquilion LB CT scanner (Canon Medical Systems
Corporation, Japan). All 4DCTs were acquired with the fol-
lowing parameters: slice collimation of 16 mm 9 1.0 mm,
helical pitch of 1.2, rotation time of 0.5 s, tube voltage of
120 kV, and tube current of 150 mA. Images were recon-
structed in 3 mm slices with pixel size of 1.074 mm and a
matrix of 512 9 512. A laser-based optical surface scanner
(SentinelTM, C-RAD AB, Sweden) has been used as to mea-
sure patient breathing motion as a surrogate for 4DCT recon-
struction. The position of the surrogate spot on each patient’s
surface has been chosen according to Heinz et al.28, on the
upper abdomen in the region of the diaphragm on the
patient’s right side. Here, less interferences with cardiac
movement, less phase shift compared to spots on the lower
abdomen, and a better signal-to-noise (SNR) due to higher
amplitude than any other spot on the surface are expected.
PTV was defined in accordance with clinical protocol as the
sum of the GTVs (to construct an ITV structure) with a
6 mm margin added in all directions. In four of the patients,
the dose to the PTV was 40.5 Gy prescribed to the 65%
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isodose line and in one patient 40.5 Gy prescribed to the
80% isodose line (both with 100% equaling DMax), delivered
over the course of three fractions. A 3D-CRT treatment plan
has been calculated based on the 3DCT dataset, according to
the standards of our institution. The breathing curves of all
patients were recorded at the Linac using an optical surface
scanner (CatalystTM, C-RAD AB, Sweden) during the whole
treatment session for all three fractions individually. Breath-
ing characteristics and tumor mobility for each individual
patient are summarized in Table I. The respiratory data col-
lection was approved by the local ethics committee of the
University Hospital, LMU Munich (No. 352-16 ex 09/2016)
and registered at the German Clinical Trials Register (DRKS-
ID: DRKS00011407). Written informed consent was obtained
from all patients. All other data processing has been con-
ducted retrospectively and has also been approved by the
local ethics committee of the University Hospital, LMU
Munich (No. 573-15 ex 10/2015).
The fraction of time in each breathing phase during 4DCT
acquisition and throughout each fraction is depicted in
Table II.
2.B. Workflow
After the clinical FB 3DCT and 4DCT acquisition (1, for
all italic references, see Fig. 1), the raw 4DCT dataset has
been resampled in order to reconstruct a local amplitude-
sorted (LAS) 4DCT dataset29 (5), in which all gross tumor
volumes (GTVs) were delineated by an experienced radiation
oncologist. Apart from the original clinical treatment plan
(2), eight different treatment plans were created: 3D-CRT (7)
and VMAT (8) plans with the dose calculation based on four
different CT sets (3DCT, average intensity projection (AIP),
maximum intensity projection (MIP, both reconstructed from
all 4D phases), and 3DCT with density overwrites according
to Wiant et al.18 (mean ITV density to the ITV and the mean
between ITV and lung density to PTV-ITV)). All VMAT
plans were optimized using Hyperion V2.4.5 (University
T€ubingen, Germany, research version of Elekta MONACO
3.2)30,31 with two full 360 arcs and a 2 mm isotropic dose
grid. 3D-CRT planning was initially performed using
Oncentra Ver4.3.0.410 (Nucletron B.V., Netherlands) with 8–
11 different beam angles with field opening covering at least
the ITV (the full motion range). All 3D-CRT plans were
afterward also recalculated with the same Monte Carlo dose
engine using Hyperion V2.4.5, resulting in a 3D Monte Carlo
dose comparable to the postplanning 4D Monte Carlo calcu-
lations. All eight plans were irradiated (9) on an Elekta Syn-
ergy Linac with an Agility Head (Elekta AB, Sweden) to
create a Linac log file (10). The log file included elapsed
time, corresponding RTPlan control point, dose rate, deliv-
ered MUs, Gantry and collimator angle, jaw positions, and
all 160 MLC positions, with a time resolution of 0.04 s. The
log file information combined with the breathing information
gathered during the actual treatment (4) were synchronized
using the “beam-on" timestamp provided directly by the
Linac interconnection through the Elekta ResponseTM inter-
face (Elekta AB, Sweden) in the recorded CatalystTM breath-
ing motion file. This allows to recalculate the dose delivery
based on 4DCTs by splitting the individual plans (11), each
with a distinct correspondence to a 4DCT breathing phase as
the patient breathing traces were also sampled to a distinct
4DCT phase using the same LAS method as has been applied
to the 4DCT reconstruction. Therefore, the breathing signal is
downsampled to the log cycle resolution of 0.04 s to obtain
the corresponding 4DCT phases during the whole delivery
and split the original plan accordingly. All plans were recal-
culated on the actual 4D-phase (12) using MCverify (with
dose-to-medium used for calculations), which is a scriptable
submodule XVMC dose engine of Hyperion V2.4.5.32–35
The resulting dose fragments were accumulated (14) using
AVID (Analysis of Variations in Interfractional Radiotherapy,
German Cancer Research Center, Heidelberg), a framework
for automatic analysis of variations in dose and geometry. In
AVID, the ten dose fragments calculated on each 4DCT
phase were merged together by first calculating the intensity-
based (using B-Splines36) deformable image registration
(Plastimatch,37) to the 50% breathing phase (13). With
the registration information, all ten dose fragments could
be accumulated, by using the dose accumulation tool of
the RTToolbox (RTToolbox38,39) eventually leading to a
4D Monte Carlo recalculated dose (15). The dose
TABLE I. Overview of tumor mobility and breathing motion characteristics during four-dimensional computed tomography (4DCT) acquisition and during treat-
ment beam-on time for each fraction. Tumor motion has been measured using an in-house developed software tool with an accuracy of 3 mm in the craniocaudal
direction and 1 mm in both left–right and anterior–posterior directions (resolution of the 4DCT reconstruction). Mean GTV has been measured over all GTVs
delineated by a radiation oncologist in the ten different 4DCT phases. ITV is the sum of all GTVs. Abbreviations: RR = respiratory rate, bpm = breaths per min-
ute, GTV = gross tumor volume, ITV = internal target volume, SD = standard deviation, CC = craniocaudal, AP = anterior–posterior, RL = right–left, Mag
(Magnitude) =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
CC2 þ AP2 þ RL2p .
Mean RR (CT) (bpm) Mean RR (Linac) (bpm) GTVmean  SDðcm3Þ ITV (cm3)
Tumor Movement (mm)
CC AP RL Mag
Pat 1 18.7 17.0 1.7  0.1 5.0 12 2 3 12.5
Pat 2 17.3 13.0 0.9  0.1 3.2 12 3 1 12.4
Pat 3 11.2 13.1 1.2  0.1 2.7 9 2 1 9.3
Pat 4 14.9 13.6 12.0  0.4 20.8 6 2 3 7.0
Pat 5 15.7 11.7 6.5  0.5 16.4 27 4 3 27.5
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interpolation in the accumulation was performed according
to the dose reconstruction scheme of Rosu et al.21. All
three treatment fraction doses were subsequently merged into
one single dose file containing the 4D accumulated dose for
comparison. An overview of the workflow can be found in
Fig. 1. The workflow, without incorporation of breathing
motion, has been previously validated in von M€unchow
et al.40
2.C. Plan evaluation
Dose–volume histograms (DVHs) of the gross tumor vol-
ume at the 50% breathing phase (GTV50%, ideally maximum
expiration) were created for all optimized treatment plans and
for the corresponding 4D dose recalculations. The minimum
dose of X% of the GTV is depicted as DX%. D98% (the mini-
mal absorbed dose covering 98% of the GTV as a robust
measure for minimum dose), D50% (the minimal absorbed
dose covering 50% of the GTV), and D2% (the minimal
absorbed dose covering 2% of the GTV as a robust measure
for maximum dose) were calculated specifically. In addition,
a dose homogeneity index (HI) has been calculated according
to ICRU Report 8341 as:
HI ¼ D2%  D98%
D50%
(1)
A HI of zero would be equivalent to an almost homoge-
neous absorbed-dose distribution. All DVHs and dose
parameters were compared to each other as “Doseoptimized"
(indicating the 3D Monte Carlo dose from the treatment
planning system) and “Doserecalculated" (indicating the 4D
Monte Carlo recalculated dose), with Doserecalculated
expected to be the closest approach to the ground truth of
absorbed dose.
3. RESULTS
Table III summarizes the dose parameters as the difference
between Doserecalculated and Doseoptimized for all five patients,
with a negative value indicating less dose observed in the dose
recalculation than with plan optimization, which would lead to
a GTV underdosage. For 3DCT-based planning, DD98% and
DD50% are higher on average over all patients for the 3D-CRT
and VMAT treatment plans with MeanDD98%;3DCRT ¼ 3:6  2:6
Gy and MeanDD98%;VMAT ¼ 3:0  4:0 Gy, while D2% experi-
ences an underdosage for 3D-CRT planning with
MeanDD2%;3DCRT ¼ 1:7  0:5 Gy. AIP-based planning
increases the low-dose (D98%) areas in the GTV
(MeanDD98%;3DCRT ¼ 2:2  3:4 Gy), slightly less using VMAT
(MeanDD98%;VMAT ¼ 0:8  1:8 Gy), while high-dose areas stay
within the same range for both treatment planning methods.
Absorbed dose in high-dose areas is in good agreement for
MIP-based planning over the patient cohort, although on
average an underdosage MeanDD2%;VMAT ¼ 2:6  2:7 Gy
and MeanDD2%;3DCRT ¼ 3:4  1:7 Gy is calculated for all
dose parameters and both treatment techniques, especially for
patient 3.
DD98% varies in the patient cohort ranging from 4.0 Gy
in patient 5 to 4.7 Gy in patient 1 (both 3D-CRT). As
expected, DO-based planning leads to an underdosage in
the GTV due to the higher density in ITV and PTV, for
3D and VMAT plans, especially in high-dose areas. There
is a decrease in HI to be observed between 4D recalcula-
tions and the optimized planning dose for most patients,
although patient 1 experiences a slight increase in homo-
geneity. Patient 4 with the largest tumor size (and there-
fore different prescription; 40.5 Gy prescribed to the 80%
isodose line) shows the least differences in most dose
parameters.
Figure 2 shows the calculated DVHs for two exem-
plary patients (Pat 2 & Pat 5) for all 3D and all VMAT
plans, each with a dose calculation based on a differ-
ent underlying CT (3DCT, AIP, MIP, DO). In patient 2,
the highest differences in the DVHs can be seen for DO
and 3DCT-based calculations. The DVHs for both AIP
and MIP-based optimization follow closely the form
of the DVHs for 4D recalculation. For patient 5,
DVH results show larger differences in AIP-based
TABLE II. Fraction of time in each breathing phase for all patients during four-dimensional computed tomography (4DCT) acquisition and during each treatment
fraction (mean value over all fractions with range [min–max]). EOI: end of inhale; EOE: end of exhale.
Pat 1 Pat 2 Pat 3 Pat 4 Pat 5
4DCT
(%)
LINAC (%)
Mean [Range]
4DCT
(%)
LINAC (%)
Mean [Range]
4DCT
(%)
LINAC (%)
Mean [Range]
4DCT
(%)
LINAC (%)
Mean [Range]
4DCT
(%)
LINAC (%)
Mean [Range]
0% (EOI) 0.18 0.13 [0.12–0.14] 0.14 0.15 [0.14–0.16] 0.14 0.18 [0.12–0.29] 0.12 0.13 [0.13–0.14] 0.14 0.11 [0.10–0.12]
10% 0.05 0.07 [0.06–0.08] 0.05 0.05 [0.04–0.06] 0.06 0.06 [0.06–0.07] 0.06 0.06 [0.05–0.07] 0.05 0.05 [0.05–0.05]
20% 0.04 0.07 [0.06–0.07] 0.03 0.04 [0.03–0.04] 0.07 0.06 [0.03–0.07] 0.07 0.07 [0.06–0.07] 0.05 0.05 [0.05–0.05]
30% 0.07 0.08 [0.08–0.08] 0.13 0.05 [0.04–0.06] 0.08 0.07 [0.03–0.10] 0.08 0.10 [0.08–0.13] 0.07 0.07 [0.07–0.07]
40% 0.08 0.11 [0.10–0.11] 0.17 0.12 [0.10–0.14] 0.13 0.09 [0.06–0.11] 0.14 0.12 [0.11–0.14] 0.13 0.13 [0.13–0.13]
50% (EOE) 0.30 0.31 [0.27–0.36] 0.20 0.39 [0.35–0.44] 0.21 0.27 [0.21–0.39] 0.25 0.28 [0.26–0.30] 0.31 0.38 [0.36–0.39]
60% 0.06 0.06 [0.06–0.08] 0.17 0.06 [0.05–0.08] 0.07 0.08 [0.06–0.10] 0.10 0.08 [0.07–0.09] 0.06 0.07 [0.07–0.07]
70% 0.05 0.05 [0.05–0.06] 0.04 0.05 [0.05–0.05] 0.09 0.07 [0.03–0.09] 0.06 0.06 [0.04–0.06] 0.06 0.05 [0.05–0.06]
80% 0.10 0.06 [0.05–0.06] 0.04 0.05 [0.05–0.05] 0.07 0.06 [0.02–0.08] 0.06 0.06 [0.05–0.06] 0.06 0.05 [0.05–0.05]
90% 0.07 0.06 [0.06–0.07] 0.04 0.06 [0.05–0.06] 0.09 0.05 [0.03–0.07] 0.05 0.06 [0.04–0.07] 0.06 0.05 [0.05–0.06]
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planning and are in better agreement using density over-
rides.
As seen in Table II, the breathing curve of patient 3
varies the most during each fraction. In order to verify
that the fraction of time in each breathing phase is
accounted for in the 4D calculations, we calculated the
4D dose exemplary for this patient with the assumption
that only fraction 3 has been treated three times (as most
variations in the breathing curve occur in this fraction
compared to the other fractions). The difference in DD2%
between the 4D calculations for all fractions accounted for
and fraction 3 only results in 0.42 Gy for 3DCT-based
planning, 0.08 Gy for AIP-based planning, 0.30 Gy for
MIP-based planning, and 0.05 Gy for DO-based plan-
ning (for VMAT treatment plans).
LAS 4DCT
Reconstruction
3D-CRT
- 3D static CT
- AIP
- MIP
- Density Override
Non-clinical
Treatment
Planning
VMAT
- 3D static CT
- AIP
- MIP
- Density Override
Clinical Treatment
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3D CT (FB) &
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Data Recorded
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FIG. 1. Scheme of the implemented workflow.
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4. DISCUSSION
Using different CT datasets for dose calculation influences
the dose distribution in various ways. In accordance with lit-
erature,1,15,17,42,43 our results also show that the clinical stan-
dard of using a simple 3DCT as a so-called “planning CT"
does not reflect the delivered dose correctly to the GTV for
tumor sites that encompass breathing-induced motion. For
small tumor sizes (see patients 2 and 3 with rather small
GTVs (0.9  0.1 cm3 and 1.2  0.1 cm3, respectively),
positive values for DD98% (minimum dose), indicating less
cold spots, have been calculated for 3D-CRT and VMAT
treatment techniques. The VMAT optimizer and the 3D-CRT
calculation algorithm do not expect tumor tissue in the ITV
due to the nature of the 3DCT, where only parts of the ITV
are filled with real tumor density. Therefore, the optimizer
calculates more monitor units to the parts of the ITV, where
less density is present in order to achieve the prescribed dose,
which obviously leads to more hot spots than originally
planned in these areas. This was found in most patients
except for patient 1, where a slight underdosage has been cal-
culated. Here, the 3DCT seems to encompass tumor motion
quite well and planning on the 3DCTwill indeed lead to simi-
lar results in the 4D calculation and plan optimization.
Using the DO method, the absorbed dose is underesti-
mated in all patients for high-dose areas (D2%). The hybrid
density override method of Wiant et al. (mean ITV density to
the ITV and the mean between ITV and lung density to PTV-
ITV)18 has been chosen as a result of their study. This speci-
fic override does not agree well with our results for patients
1–3. The calculated underdosage in the 4D calculations is
observed throughout these patients and cannot be
TABLE III. Dose parameters D98%, D50%, D2%, and the homogeneity index HI, depicted as difference between Doserecalculated and Doseoptimized for both calcula-
tion methods [three-dimensional-conformal radiation therapy (3D-CRT) and volumetric arc modulated treatment (VMAT)] and all four underlying computed
tomographies (CTs) [three-dimensional CT (3DCT), average intensity projection (AIP), maximum intensity projection (MIP), density overrides (DO)]. Negative
values indicate an underdosage in the four-dimensional (4D) recalculation, positive values are a result of more absorbed dose in the 4D calculations than planned.
SD = standard deviation.
Base CT
3D-CRT VMAT
3DCT AIP MIP DO 3DCT AIP MIP DO
Pat 1
DD98% (Gy) 0.6 3.5 4.6 6.0 1.0 2.5 2.3 4.2
DD50% (Gy) 0.7 0.4 3.2 5.1 0.1 0.0 1.0 2.6
DD2% (Gy) 1.6 2.0 4.5 7.2 0.7 0.0 2.0 2.3
DHI(%) 0.02 0.03 0.02 0.00 0.00 0.05 0.01 0.04
Pat 2
DD98% (Gy) 5.7 1.9 0.1 1.9 9.1 1.8 0.4 2.9
DD50% (Gy) 1.9 0.8 0.5 2.6 2.4 1.7 1.5 1.4
DD2% (Gy) 1.0 1.0 2.5 3.9 1.4 0.8 0.6 3.5
DHI(%) 0.13 0.05 0.04 0.09 0.15 0.02 0.00 0.12
Pat 3
DD98% (Gy) 6.8 3.3 1.7 5.6 6.2 3.0 3.9 2.6
DD50% (Gy) 5.8 3.8 1.3 6.7 6.9 4.3 3.0 6.2
DD2% (Gy) 2.2 0.5 6.3 7.8 0.3 1.5 4.3 7.2
DHI(%) 0.20 0.08 0.08 0.01 0.15 0.05 0.01 0.05
Pat 4
DD98% (Gy) 2.5 2.5 1.8 0.9 0.6 1.0 1.9 0.6
DD50% (Gy) 1.0 1.2 0.8 0.2 0.9 1.1 1.0 1.2
DD2% (Gy) 2.1 1.6 1.6 2.5 0.3 0.9 0.4 2.5
DHI(%) 0.10 0.09 0.07 0.07 0.01 0.01 0.05 0.04
Pat 5
DD98% (Gy) 3.3 7.0 4.0 0.1 1.1 0.6 2.0 0.6
DD50% (Gy) 2.4 4.4 2.1 0.9 1.3 1.4 0.3 1.1
DD2% (Gy) 1.4 0.1 2.2 3.6 0.6 0.7 6.9 3.4
DHI(%) 0.09 0.14 0.12 0.06 0.04 0.03 0.19 0.06
Mean  SD
DD98% (Gy) 3.6  2.6 2.2  3.4 0.1  3.0 1.7  3.4 3.0  4.0 0.8  1.8 0.4  2.3 1.0  2.4
DD50% (Gy) 2.4  1.8 2.1  1.6 0.4  1.8 3.1  2.5 1.9  2.7 1.7  1.4 0.2  1.6 2.5  1.9
DD2% (Gy) 1.7  0.5 1.0  0.8 3.4  1.7 5.0  2.1 0.0  0.8 0.5  0.8 2.6  2.7 3.8  1.8
DHI(%) 0.11  0.06 0.07  0.05 0.06  0.04 0.05  0.03 0.07  0.07 0.01  0.03 0.05  0.08 0.04  0.05
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recommended for SBRT treatments for patients with a small
GTV size. For large tumor motion (see Pat 5 with 27.5 mm
motion magnitude) and larger tumor sizes (see Pat 4 with
GTVmean = 12.0  0.4 cm3), the density override scheme
does fit best in high-dose areas for 3D-CRT and VMAT
plans. It is possible that different density overrides (i.e., only
overriding the ITV with a certain density) can achieve better
results, but this would have to be determined in future
studies.
For our small patient cohort, we observed only minor dose
differences (in terms of D ¼ Doserecalculated  Doseoptimized) in
AIP- and MIP-based VMAT generations and 3D-CRT treat-
ment plans. Huang et al. evaluated an underdosing (over
10%) in some PTV areas for tumors moving irregularly with
a larger range when calculating the Monte Carlo 4D dose on
AIP and MIP based on the 4DCT dataset.16 The dose differ-
ence in patient 1 agrees with these results, as also an under-
dosage is calculated in the 4D dose. For patient 5, with the
largest motion amplitude, overdosages in AIP planning are
visible. In our study, we only measure the tumor motion
based on the surrogate during the treatment time at the Linac,
breathing irregularities could not be evaluated thoroughly.
We assume that the surrogate motion signal at the patient’s
surface represents tumor motion, which in reality is not the
case due to the nature of breathing motion, which is highly
irregular and can contain abnormalities even within a short
period of time. An enhancement of our study would be the
direct monitoring of the tumor itself (e.g., in MV/kV projec-
tions) and not monitoring a surrogate. Also, Rosu and Hugo
note that for an ideal true 4D workflow, online predictive res-
piratory motion monitoring or real-time tumor tracking (us-
ing implantable radiopaque markers44,45 or MV/kV portal
images46–48) would be needed.26 This could be used to create
a more realistic representation of the patient compared to the
4DCT acquired days before treatment and to minimize the
chances of the 4DCT being an incorrect surrogate of the anat-
omy at treatment day. The possibility of time-resolved errors
is investigated in the exemplary calculation of patient 3 with
the highest breathing variability: The potential effects of dose
uncertainties due to changes in the patient breathing pattern
are explicitly incorporated in our calculations, even if they
are neither quantified nor disentangled. The additional com-
plexity in our approach with the calculation based on the
Linac log files would also explicitly account for possible
machine-related errors and interplay effects.
We did not observe an interplay effect between dynamic
MLC movement and tumor motion in this patient cohort, as
the differences in dose parameters are within the same range
for 3D and VMAT treatments. For SBRT treatments, the
interplay effect has little to no effect in the examination of the
data of the five patients here. 3D-CRT treatment plans even
show higher dose differences between plan recalculations and
originally generated plans for all types of underlying CTs in
comparison with VMAT plan optimizations. This is due to
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FIG. 2. Dose–volume histograms (DVHs) for two exemplary patients (Pat 2 & Pat 5): three-dimensional computed tomography (blue), average intensity projec-
tion (magenta), maximum intensity projection (green), and density overrides (brown) for the four-dimensional recalculations (solid) and the optimized treatment
plan (dashed). Subfigures (a) and (c): three-dimensional-conformal radiation therapy treatment planning; Subfigures (b) and (d): volumetric arc modulated treat-
ment plan optimization. [Color figure can be viewed at wileyonlinelibrary.com]
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the fact that for SBRT VMAT treatments, the ITV structure
(as the sum of all GTVs) is completely enclosed by most of
the segments. Furthermore, the way that the PTV dose is pre-
scribed could influence the calculations. In this study, we use
the same dose specifications for 3D-CRT planning and
VMAT inverse optimization: Prescribing the desired isodose
level (65% or 80 %) to the PTV and limiting the maximum
dose in the PTV to 100% (for 3D-CRT planning directly and
for VMAT optimization using a quadratic overdose con-
straint). Rao et al. investigated the interplay effect for VMAT
and IMRT treatment plans and found it to be negligible.43
This is in accordance with our results, as an interplay effect
could not be observed when comparing all VMAT with the
3D-CRT treatment plans. Only for patient 2 with very small
tumor volume (GTVmean = 0.9  0.1 cm3), the data indicate
a possible interplay effect. Contradictory to our results, Ehr-
bar et al. found tumor motion effects in VMAT treatments as
negligible.49 They have recommended the use of AIP with
3D dose calculations as sufficient for treatment planning.
Even for this recommended AIP-based treatment planning,
we have found dose differences that are not negligible,
depending on the motion characteristics of the individual
patient.
The evaluation of 4D dose takes time and effort, as the
dose has to be calculated on multiple 4DCT breathing phases.
A different approach to 4D dose calculations has been inves-
tigated by Valdes et al.50: They use 4D dose accumulation by
deformable image registration without the need of recalcula-
tion, which might serve as a tool to accelerate calculation
time and limit effort. It is a direct extension of Guckenberger
et al.42, where it was found that the dose to the GTV remains
constant over all 4DCT phases. This is only true for treatment
plans, where all fields (3D-CRT) or most segments (VMAT)
encompass target motion (in our case: the ITV). With fields
or segments large enough, one calculation and subsequent
4D deformable image registration can be sufficient. For smal-
ler fields or segments, which do not encompass the full target
motion range, the results might look different.
An evaluation of dose-limiting OAR structures would also
be of high interest. But as the 4DCT scans have been only
acquired within a range of 51 mm above and below the tumor
(in CC direction, examined in the 3DCT prior to 4DCT imag-
ing) due to the clinical protocol, this could not be achieved in
this study and will be of high interest in future works. A dosi-
metric evaluation of important OAR structures such as heart,
esophagus, or other was not possible within our patient
cohort. OAR structures were not anywhere near the PTV and
due to the high-dose gradient, OAR structures are only
affected with minimal absorbed dose. Any detailed statistical
evaluations (i.e., correlations between the magnitude in
motion or GTV size and dose differences) could not be car-
ried out due to the small patient cohort. Due to the high cal-
culation effort for each patient, the patient cohort could not
be extended for this work, but additional dose calculations
for patients with different individual tumor sizes, motions,
and breathing patterns are planned in the near future, in order
to statistically validate for which type of tumor motion the
various types of CT datasets can be used best. No distinct rec-
ommendation on which CT dataset should be used for SBRT
treatment planning can be made from the results of our study.
As described above, current literature is also not in congru-
ence on this specific topic. Tumor motion is always highly
patient specific and the variability of our results and other
studies are always highly dependent on certain factors, such
as dose calculation algorithm, clinical treatment concept, cre-
ation of the PTV with different margins, having open fields/
segments encompassing all target motion, but most impor-
tantly it is dependent of the patient’s individual tumor motion
and breathing pattern. Gauer et al. recently found an influ-
ence of interplay effects for target motion with abnormal vari-
ability (in phantom measurements),51 which also indicates
the patient-specific character of breathing-induced tumor
motion.
Potential errors in the deformable registration process
could induce errors in dose mapping. Using the 50% breath-
ing phase as a reference CT for registration performs well
when inspecting the registration result optically. The dose
mapping itself could also lead to significant errors. The dose
interpolation method of Rosu et al.21, which has been used
for the accumulation process, has limitations in regions of
strong density variations where the partial volume effect is
still relevant.52 According to Rosu et al.21, who recommended
a dose grid size of 3–4 mm to adequately minimize interpola-
tion errors, we have used a 3 mm size in our calculations.
The stochastic uncertainty from the Monte Carlo dose calcu-
lation was below 1% for all plans and by using the same
Monte Carlo dose engine, stochastic variations are within the
same range for all 4D recalculations (Doserecalculated) and 3D
plan generations (Doseoptimized).
There is an intermediate step leading to the clinical imple-
mentation of the workflow described above: modern treat-
ment planning systems (TPS) should at least be able to
calculate dose on each phase of a 4DCT (without dose warp-
ing or any attention on interplay effects at this point). This
simple step could already give an idea of the treatment plan
quality for moving targets. For a future perspective, an adap-
tion of this workflow with Monte Carlo 4D recalculations
and only few assumptions could be added to modern TPS:
With a full 4DCT dataset and the patient’s breathing curve
recorded over a longer period of time (i.e., before and during
4DCT acquisition), it can be calculated in advance how a 4D
dose distribution could behave, depending on certain variabil-
ity in breathing motion. The, both patient-specific, 4DCT
dataset and breathing surrogate are the essential part of a sim-
plified workflow. This could lead to an a priori awareness of
the patient-specific 4D dose distribution, which has so far not
been incorporated in modern TPS. A general recommenda-
tion on which CT should be used for lung SBRT cannot be
provided due to the limitations of this study, but our results
indicate that the risk of over- or underestimating tumor move-
ment (as it is present for MIP-based calculations15) is least
probable for AIP-based dose calculations.
The workflow presented in this study is, to our best knowl-
edge, the first implementation of 4D Monte Carlo dose
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recalculations using the actual breathing trace of a patient
during each individual radiotherapy fraction. Using local
amplitude-based 4DCT sorting and the same method for
assigning the breathing waveform to the individual 4DCT
phases leads to a good approximation of the actual treated
dose (within the limitations stated above).
5. CONCLUSION
We have developed a workflow which is, to our best
knowledge, the first 4D Monte Carlo dose recalculation using
the Linac’s log file and the actual patient breathing trace. An
approximation of the actual absorbed dose to a 4DCT dataset
can calculated for a comparison to the planned dose. This
workflow allows us to evaluate if interplay effects have to be
accounted for during VMAT treatment plan optimization and
helps to decide which CT should be used as a basis for dose
calculation and optimization. For 3DCT datasets as a calcula-
tion basis, the highest differences between optimized and
recalculated dose were observed. MIP and AIP CT datasets
were found to produce the least dose differences, while the
risk of over- or underestimating tumor motion is higher for
MIP datasets. Also, density overrides can be useful for
patients with a high tumor motion range. Overall, both MIP
and AIP datasets tend to be superior for accurate treatment
planning with regards to moving tumors. Due to the highly
patient-specific character of breathing motion, a general rec-
ommendation cannot be provided. Our workflow could, after
optimizing the techniques for clinical use, help to provide a
4D dose calculation tool in modern TPS, where the effects of
tumor motion have not been incorporated enough up to this
point.
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Abstract
Background: Knowing the technical characteristics of gated radiotherapy equipment is crucial for ensuring precise and
accurate treatment when using techniques such as Deep-Inspiration Breath-Hold and gating under free breathing. With
one of the first installations of the novel surface imaging system Catalyst™ (C-RAD AB, Sweden) in connection with an
Elekta Synergy linear accelerator (Elekta AB, Sweden) via the Elekta Response Interface, characteristics like dose delivery
accuracy and time delay were investigated prior to clinical implementation of gated treatments in our institution.
Methods: In this study a moving phantom was used to simulate respiratory motion which was registered by the
Catalyst™ system. The gating level was set manually. Within this gating window a trigger signal is automatically sent to
the linac initiating treatment delivery. Dose measurements of gated linac treatment beams with different gating levels
were recorded with a static 2D-Diode Array (MapCheck2, Sun Nuclear Co., USA) and compared to ungated reference
measurements for different field sizes. In addition, the time delay of gated treatment beams was measured using
radiographic film.
Results: The difference in dose delivery between gated and ungated treatment decreases with the size of the chosen
gating level. For clinically relevant gating levels of about 30%, the differences in dose delivery accuracy remain below
1%. In comparison with other system configurations in literature, the beam-on time delay shows a large deviation of
851 ms ± 100 ms.
Conclusions: When performing gated treatment, especially for free-breathing gating, factors as time delay and dose
delivery have to be evaluated regularly in terms of a quality assurance process. Once these parameters are known they
can be accounted and compensated for, e.g. by adjusting the pre-selected gating level or the internal target volume
margins and by using prediction algorithms for breathing curves. The usage of prediction algorithms becomes
inevitable with the high beam-on time delay which is reported here.
Keywords: Respiratory gating, Catalyst, Latency, Dosimetry
Background
Respiratory motion is still one of the major sources for
uncertainties in thoracic and abdominal treatment sites
in radiation therapy. The accuracy of dose delivery can
be increased by respiratory-adapted gating or breathing
control [1]. Accounting for intrafraction motion solely
by increasing the treatment margins will increase the
volume of normal tissue being irradiated with high doses
[2]. Therefore techniques to minimize treatment mar-
gins are highly desirable. With the introduction of gated
treatments, in which the beam is only activated during
specific motion phases (the so-called gating window),
[3,4] the increased organ-at-risk (OAR) dose can poten-
tially be reduced to a minimum. Gated treatment has
the potential to reduce lung dose for the radiotherapy of
thoracic esophageal carcinoma using Deep-Inspiration
Breath-Hold (DIBH) techniques [5] and it is considered
reliable and effective for patients with high tumor
movements in stereotactic body radiotherapy (SBRT) [6].
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In order to ensure precise and accurate treatment several
gating characteristics, including dose delivery accuracy,
overall latency, and temporal accuracy of the applied sys-
tem have to be known in advance [7]. Gating is initiated
with different respiratory monitoring systems at the mo-
ment and various studies have been performed in order to
assess the differences between them [8-11]. Several others
additionally investigated the question whether or not a
linac is able to being gated, [3] or the linac’s performance
under gated treatment [12-14].
So far the novel surface imaging system Catalyst™
(C-RAD AB, Uppsala, Sweden) in connection with an
Elekta Synergy linear accelerator (linac) with Agility Head
(Elekta AB, Stockholm, Sweden) and connectivity be-
tween those two systems via the Response™ gating inter-
face (Elekta AB, Stockholm, Sweden) has only been
examined by calculating theoretical time delays for this
system configuration [15]. Dose delivery and time delay
have already been measured for other vendors. However,
the characteristics of this specific system setup are not
known yet. Technically, the gated delivery is being per-
formed by the Response™ interface, which interrupts the
RF source during the beam-off period [16]. Our main
focus in this study is therefore not only the time delay of
the optical surface scanner for the treatment initiation,
but the overall system latency, which includes all parts
that could possibly delay beam initiation.
Methods
In this study, the gating signal used for the linac is deliv-
ered by a surface imaging system. A Dynamic Thorax
Phantom (CIRS Inc., Norfolk, VA, USA) was used to
simulate a breathing waveform, which is then measured
by the Catalyst™ system. One of the first steps of inte-
grating a system based on optical surface measurements
was to extend our movement phantom (Figure 1, left).
There was a need to construct a surface which can be
detected by the surface scanner and reproduces breath-
ing patterns imitating natural physiology. Thermoplastic
mask material was mounted to the vertical motion plat-
form of the phantom to mimic a human thorax and to
create a surface visible for the scanner.
After defining a measurement point on the phantom sur-
face, the vertical movement is recorded by the commer-
cially available Catalyst™ software. The gating level, which
in contrast to other commercially available monitoring sys-
tems is a spatial gating window in a specific millimeter
range, is set manually. Whenever the point of measurement
is detected within the gating level a trigger signal is sent
automatically to the linac, initiating treatment delivery.
Dose measurements
In order to measure possible dose differences induced
by gated treatment a 2D-Diode Array (MapCheck2, Sun
Nuclear Co., Melbourne, FL, USA) was set up stationary.
Ungated dose delivery was defined as reference and the
absolute dose of the delivery using several gating levels
was compared against this reference dose. The array was
placed isocentric in SSD = 100 cm and gating levels were
chosen as 50%, 40%, 30%, 20%, and 10% of a modulated
sine wave simulated by the moving phantom and a total
of 300 monitor units (MU) per measurement were
Figure 1 Left: Image of the build-up for the dynamic moving phantom. The surface is reconstructed using mask material. Right: The
phantom as it is perceived by the Catalyst™ software.
Freislederer et al. Radiation Oncology  (2015) 10:68 Page 2 of 6
Paper 3 75
applied. Measurements were repeated three times for
each gating level for two different field sizes (10 ×
10 cm2 and 20 × 20 cm2).
Time delay measurements
An extension to the existing phantom for the applica-
tion of radiographic films (Gafchromic® EBT, Inter-
national Specialty Products, Wayne, NJ, USA) was built
in order to move the film horizontally through the
gated beam (Figure 2). As the film moves through a
rectangular field with 2 cm × 2 cm field size with 6 cm
peak-to-peak amplitude (sinusoidal motion trajectory),
blackening of the film due to irradiation is expected in
a 2 cm by 5 cm rectangle (2 cm in width and height
due to the field size and an additional 3 cm in height
due to the gating window of 50% of the film move-
ment) in an ideal case of no time delay in the overall
system. The gating level was set to 50% (see Figure 3)
for sinusoidal film movements, as at this level the film
is moving with minimal acceleration and constant vel-
ocity. With a blackening of the film exceeding the ideal
(“no time delay”) blackening with a certain length (ΔL)
for beam off time delay (ΔtBEAM-OFF) and vice versa for
beam on time delay (ΔtBEAM-ON), these two measures
can by calculated for the known velocity (v) of the film
at this level by Δt = ΔL / v. Figure 3 shows the sche-
matic measurement principle. For a more detailed de-
scription of principle of the methods see Smith &
Becker [8]. The overall time delay is calculated as a
mean value from in total 6 measurements for each
beam-on and beam-off time delay. The blackening of
the film and consequently the length L was chosen as
the part where it has reached its maximum intensity,
which is equivalent to the linac reaching its maximum
dose rate.
Results
Dose measurements
Measured differences in dose delivery between gated and
ungated treatment averaged over the whole field size can
be seen in Table 1. The total delivered dose decreases
with the size of the gating window. With a gating win-
dow of only 10% of the breathing cycle in a 10 × 10 cm2
field, a dose reduction of 2.15 ± 0.05% can be observed.
In addition, the treatment time for such a gating window
as narrow as 10% would be increased by a factor 10 in
comparison with ungated treatment. For a larger field
size of 20 × 20 cm2 a dose reduction of 1.62 ± 0.05% is
measured in contrast to ungated treatment. The absolute
number of start-up processes of the linac are naturally
dramatically increased when reducing the gating window
while maintaining the same amount of MUs. The rela-
tionship between dose uncertainties and the number of
start-up processes (in our case about 70–90 using a 10%
gating window and about 5–7 with a 50% gating win-
dow) becomes obvious. For larger (and therefore tem-
porally longer) gating windows which are window sizes
with more practical and clinical relevance, the differ-
ences in dose delivery accuracy decrease below 1%.
Time delay measurements
We found a value of ΔtBEAM-OFF = 215 ± 69 ms for the
system latency for beam off. For the latency of the
beam-on time, however, a value of ΔtBEAM-ON = 851 ±
100 ms has been measured, which is in contrast to
current literature, in which delays smaller than 300 ms
have been reported [16]. With the current setup for film
measurements, the relatively high standard deviation of
100 ms is explainable through measurement uncertain-
ties due to the resolution of the film, the scanning pro-
cedure, and the determination of the starting point of
ΔL. It is crucial to define the timepoint (or point on the
film respectively), that allows for a clear blackening of
the film which occurs when the linac has reached its
maximum dose rate. The dose rate varies uncontrollably
during each start-up procedure of the linac due to its
transient response, which can be seen as a reason for the
high time delay.
Discussion
The dose delivery accuracy is comparable to current lit-
erature. Evans et al. reported dosimetric differences
below 1% for beam-on times higher than 0.5 s with a
comparable linac from the same manufacturer [16]. In
our case, this beam-on-period would be comparable to a
gating window of about 30% where the difference in
dose has also been measured below 1%. Even when re-
garding different linac vendors, dosimetric differences
stay constant at around the same level, although only
larger gating windows have been evaluated [3]. A direct
Figure 2 The custom-built extension for the film measurements.
Here the extension is placed on the moving rod of the phantom and
is moved only in the horizontal direction (red arrow).
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comparison of respiratory monitoring systems is not
possible, since most of these have been evaluated with
Varian linacs, [9,11] or for proton treatment sites [4].
However the data found in literature is not comparable
to the findings in this study as Varian uses a different
gating approach. For example, the BrainLAB ExacTrac
gating system (BrainLAB, Feldkirchen, Germany) in
combination with the Varian real-time position manage-
ment (RPM) gating system (Varian Medical Systems,
Palo Alto, CA, USA) were found to have a tracking time
delay for the monitoring system only of 200 ± 30 ms and
90 ± 10 ms time delay for beam-on and beam-off times
respectively, but there is no mention about the start-up
process of the linac afterwards and the subsequent dose
delivery to the patient [10].
The method for measuring the system latency has
been adapted from Smith & Becker [8]. This particular
method proves to be efficient and accurate enough in
order to measure the overall time delay. Another
method has recently been proposed by Cui et al., [15]
which, however, does not measure the time delay for
each start-up process, does not incorporate the beam-off
delay, and the variable dose rate cannot be distinguished
in their measurements. In our measurement setup, the
time when dose rate variations occur during each start-
up process are not considered as beam-on. However the
investigators propose options for the optimization of this
issue by changing certain parameters of the linac, such
as the gun hold-on time (GHT), which is by default at a
level of 1.38 s. Increasing this parameter causes the elec-
tron gun to stay in an active state rather than switching
to standby mode. Once the electron gun reaches this
standby mode, it consequently takes longer to be in a
stabilized active mode again [15]. This is an interesting
point which is to be determined in the future at our site,
as also further dosimetric measurements have to be per-
formed. However, increasing the GHT could result in a
lower life time of the electron gun and is a setup which
has to be measured in a different way. Up to this point
only DIBH techniques are implemented at our site,
hence the lower GHT is to be considered as the regular
system setup.
Besides others, two main effects contribute to the
overall system latency, composed by the time delay of
the surrogate system (in our case the optical surface
scanner) and the time delay of the linac itself. The rather
high beam-on time delay of about 850 ms reported here
is expected to have its source primarily in the time delay
of the linac. According to Lund University [priv. comm.],
the mean time delay of the surrogate alone has been
measured with about 162 ms for beam-on time and
262 ms for beam-off time using a pneumatic piston in
order to generate the breathing pattern. They have mea-
sured the time between the output of a trigger signal
Figure 3 Left: Ideal case with the absence of time delay. The blackening of the film on the bottom has the exact length of the desired
irradiation. Right: Real case with system latency: There is a difference in exposure length between the BEAM-ON signal and the actual exposure
of the film (ΔLBEAM-ON) and a difference between the termination signal of the linac and the actual termination of the beam (ΔLBEAM-OFF). Both of
these can be measured and with a given velocity, the time delay of the system (ΔtBEAM-ON and ΔtBEAM-OFF) can therefore be calculated. The
schematic blackening of the film on the bottom of each subfigure is a transposition of the film onto the time axis, as ΔL behaves linear
proportional to the time delay Δt for given velocities.
Table 1 Results of the dose measurements for two
different field sizes: for both field sizes, there is a
decrease in dose relative to ungated treatment when
reducing the gating level and therefore increasing the
number of start-up processes and delivery time
Gating level Relative dose
(10 x 10 cm2 field)
Relative dose
(20 x 20 cm2 field)
50% 99.41 ± 0.07% 99.59 ± 0.05%
40% 99.43 ± 0.04% 99.53 ± 0.04%
30% 99.45 ± 0.52% 99.46 ± 0.04%
20% 98.81 ± 0.05% 99.09 ± 0.05%
10% 97.85 ± 0.04% 98.28 ± 0.05%
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and the change in piston position digitally, which could
not be performed in our site, but would be a valid way
of determining the latency of the surrogate system alone.
The beam-off delay of 262 ms for the surrogate system
alone is higher than the beam-off delay for the whole
treatment chain measured here as we were able to per-
form our measurements with a newer software version
of the surrogate system.
The difference in dose and the time delay for beam-on
are due to the fact, that every start-up process of the
linac is accompanied by a particular uncertainty because
of the linac’s transient response. The choice of the duty
cycle is crucial: With a decrease in dose of about 2% at
the 10% duty cycle and an increased treatment time,
awareness is needed when deciding on how far margins
should be reduced through gated treatment: There will
always be a trade-off between choosing a smaller gating
window to reduce margins as far as possible, which re-
duces residual geometric errors against having this smaller
gating window enhance possible dosimetric errors.
Predictive algorithms for respiratory motion imple-
mented in the software of the optical surface scanner
could potentially compensate for errors caused by time
delays. Up to this point, such algorithms can predict re-
spiratory motion up to 1000 ms [17]. Of course, the
quality of these prediction methods is still limited up to
a certain extent and larger time delays, as they have been
measured here, will also be harder to compensate for,
even with a prediction of respiratory motion. A detailed
overview of different prediction models and approaches
can be found in [18]. As interfractionally both the tumor
position and the gating window can change throughout
the course of the entire treatment, [19] a periodical up-
date for these will also be required.
Once parameters like time delay and dose distribution
are known, they have to be accounted for and compen-
sated by for example adjusting the pre-selected gating
level or the internal target volume (or also the clinical
target volume, CTV) margins.
Conclusions
When performing gated treatments, especially free-
breathing gating, it is crucial that factors such as time
delay and dose delivery accuracy have to be determined
in advance. In addition regularly QA-measurements as
proposed by the AAPM Task Group 76 [2] need to be
performed in order to assure stability over time. Our
data also indicates the need for the usage of predictive
algorithms describing the breathing curves whenever the
curves are finally used for gated treatments.
The examined system setup can and is being used for
techniques such as DIBH, where a high time delay of
about 850 ms is automatically compensated up to a cer-
tain extend due to longer gating cycles with less start-up
processes of the linac. When it comes to free-breathing
gating, certainly some parameter changes (such as the
GHT) in the linac and the proposed prediction methods
are essential.
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Chapter 9
Conclusion
As SBRT of lung tumors suffers from uncertainties due to the patient-specific respiratory
breathing motion, every step in the ”chain of radiotherapy” has to be performed with
special attention for precise and accurate treatment. In this thesis, three specific optimiza-
tion strategies for improvement of SBRT have been discussed: Investigation of different
4DCT reconstruction methods for reliable tumor delineation during treatment planning,
4D Monte Carlo dose calculation on different CT datasets for optimization of the SBRT
treatment planning process, and validation of respiratory gating in a clinical setup.
9.1 4DCT Reconstruction
Treatment planning for lung SBRT requires accurate motion compensation during the
course of the treatment planning process. In the presence of artefacts induced by the
4DCT reconstruction method, errors in the subsequent delineation process can lead to
substantial dose deviations. As the clinical workflow prior to the work of this thesis using
cycle-based sorting (CBS) without maximum inspiration detection (and therefore no clear
starting point for the individual breathing cycles) for 4DCT acquisition and reconstruction
could over- or underestimate the full tumor motion range, two additional reconstruction
methods have been implemented and optimized. An improved version of the CBS with
correct maximum inspiration detection and additionally a novel local amplitude-based
sorting (LAS) algorithm have been implemented. Both binning algorithms proved capable
to reduce the effect of tumor mis-representation compared to the previously used CBS
approach in a patient and a phantom study. But as the LAS method was impractical for
clinical use due to restrictions from the manufacturers and various manual intermediate
steps, the improved CBS method has been implemented clinically. This approach with
accurate maximum inspiration detection is used in the Department of Radiation Oncology
of the LMU University hospital clinically ever since the first implementation, as it requires
minimal extra workload while offering improved 4DCT image quality.
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9.2 Four-dimensional Treatment Planning
A 4D Monte Carlo dose recalculation workflow using the LINAC’s log file and the actual
patient breathing has been implemented in a research platform. The question on which
CT should be used as a basis for dose calculation could not been finally answered due
to the limited patient number, but one can conclude that the patient-specific respiratory
breathing character remains a considerable source of uncertainty in the SBRT treatment
planning process, if not accounted for properly. In addition, dose calculations merely on
3D CT datasets were found to yield the highest differences between the planned and the
4D recalculated dose. The findings of this study emphasize the need for a 4D Monte Carlo
dose calculation tool, which incorporates the effects of tumor motion (which has not been
implemented so far in modern TPS).
9.3 Respiratory Gating
The capabilities and characteristics of a medical LINAC for respiratory gating have to be
determined before clinical implementation. Once certain parameters, such as beam-on and
beam-off time delay and dose delivery accuracy are known, they have to be accounted
for and compensated. The compensation can either be performed by increasing the PTV
margins, which would contradict the whole idea of respiratory gating, or with the adjust-
ment of the gating window, which is not a trivial task in the presence of non-stationary
intrafractional motion. A trade-off between a decrease in gating window size to reduce
margins and therefore residual geometric errors and the possibility of increased dosimet-
rical errors due to smaller gating windows remains a major challenge. In the setup used
at the Department of Radiation Oncology of the LMU University hospital, dose delivery
accuracy was found to be in the same range for gated and non-gated treatments, while a
substantial time delay has been measured. This emphasizes the need of predictive algo-
rithms for respiratory motion to compensate for the LINAC time delay. In the absence of
these algorithms for clinical use, respiratory gating can only be performed where the time
delay is not of importance (for example using the DIBH technique with stable breath-hold
conditions). With regard to the measured LINAC characteristics, gated treatment based
on the patient’s duty cycle should only be performed, if a predictive motion model, which
is able to provide a periodical update of tumor position and gating window to account for
both intra- and interfractional respiratory motion uncertainties, is present.
9.4 Final Remarks
The management of the highly patient-specific respiratory motion in lung SBRT will remain
a research field with many current and future issues to be addressed. The findings of this
thesis have contributed substantially to improving the clinical workflow at the Department
of Radiation Oncology of the LMU University hospital. Nevertheless, much effort has to be
made additionally to enhance the possibilities of lung SBRT. The safe further reduction
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of treatment margins for an increased sparing of organs-at-risk (OARs) at equal tumor
coverage is one of the main goals in the future of SBRT. 4D treatment planning with
4DCT image acquisition and 4D treatment delivery with real time tumor monitoring and
an online respiratory prediction model could serve as the one ideal workflow for lung (and
other) SBRT treatment sites. Implementation of such advanced workflows will require a
close collaboration between researchers and manufacturers, with constant attention to the
end goal of clinical application.
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